---------------------------------------------------------------

[2020-03-11T13:43:55+08:00] ::1 GET localhost/tumor/public/index.php/admin/login
[运行时间：0.163154s] [吞吐率：6.13req/s] [内存消耗：3,679.48kb] [文件加载：69]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/login',
  'route' => '@admin/login/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'none',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\login\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T13:43:55+08:00] ::1 GET localhost/tumor/public/index.php/captcha
[运行时间：0.099683s] [吞吐率：10.03req/s] [内存消耗：2,897.50kb] [文件加载：57]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'captcha/<id?>',
  'route' => '\\think\\captcha\\CaptchaController@index',
  'option' => 
  array (
    'merge_rule_regex' => false,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'sec-fetch-mode' => 'no-cors',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'accept' => 'image/webp,image/apng,image/*,*/*;q=0.8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
---------------------------------------------------------------

[2020-03-11T13:43:57+08:00] ::1 GET localhost/tumor/public/index.php/captcha?vt=0.7656208180189576
[运行时间：0.083913s] [吞吐率：11.92req/s] [内存消耗：2,898.06kb] [文件加载：57]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'captcha/<id?>',
  'route' => '\\think\\captcha\\CaptchaController@index',
  'option' => 
  array (
    'merge_rule_regex' => false,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'sec-fetch-mode' => 'no-cors',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'accept' => 'image/webp,image/apng,image/*,*/*;q=0.8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'vt' => '0.7656208180189576',
)
---------------------------------------------------------------

[2020-03-11T13:44:01+08:00] ::1 GET localhost/tumor/public/index.php/captcha?vt=0.7656208180189576?vt=0.3658295297556522
[运行时间：0.081709s] [吞吐率：12.24req/s] [内存消耗：2,897.79kb] [文件加载：57]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'captcha/<id?>',
  'route' => '\\think\\captcha\\CaptchaController@index',
  'option' => 
  array (
    'merge_rule_regex' => false,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'sec-fetch-mode' => 'no-cors',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'accept' => 'image/webp,image/apng,image/*,*/*;q=0.8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'vt' => '0.7656208180189576?vt=0.3658295297556522',
)
---------------------------------------------------------------

[2020-03-11T13:44:03+08:00] ::1 GET localhost/tumor/public/index.php/captcha?vt=0.7656208180189576?vt=0.3658295297556522?vt=0.9617748746788322
[运行时间：0.077187s] [吞吐率：12.96req/s] [内存消耗：2,898.16kb] [文件加载：57]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'captcha/<id?>',
  'route' => '\\think\\captcha\\CaptchaController@index',
  'option' => 
  array (
    'merge_rule_regex' => false,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'sec-fetch-mode' => 'no-cors',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'accept' => 'image/webp,image/apng,image/*,*/*;q=0.8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'vt' => '0.7656208180189576?vt=0.3658295297556522?vt=0.9617748746788322',
)
---------------------------------------------------------------

[2020-03-11T13:44:05+08:00] ::1 GET localhost/tumor/public/index.php/captcha?vt=0.7656208180189576?vt=0.3658295297556522?vt=0.9617748746788322?vt=0.2535229825722778
[运行时间：0.071790s] [吞吐率：13.93req/s] [内存消耗：2,898.31kb] [文件加载：57]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'captcha/<id?>',
  'route' => '\\think\\captcha\\CaptchaController@index',
  'option' => 
  array (
    'merge_rule_regex' => false,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'sec-fetch-mode' => 'no-cors',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'accept' => 'image/webp,image/apng,image/*,*/*;q=0.8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'vt' => '0.7656208180189576?vt=0.3658295297556522?vt=0.9617748746788322?vt=0.2535229825722778',
)
---------------------------------------------------------------

[2020-03-11T13:44:14+08:00] ::1 POST localhost/tumor/public/index.php/admin/login
[运行时间：0.540203s] [吞吐率：1.85req/s] [内存消耗：6,086.35kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/login',
  'route' => '@admin/login/loginHandler',
  'option' => 
  array (
    'merge_rule_regex' => false,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '40',
  'cache-control' => 'max-age=0',
  'origin' => 'http://localhost',
  'upgrade-insecure-requests' => '1',
  'content-type' => 'application/x-www-form-urlencoded',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'username' => 'admin',
  'password' => 'admin',
  'vcode' => 'bfub',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.170019s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_users` [ RunTime:0.115215s ]
[ sql ] [ SQL ] SELECT * FROM `tp_users` WHERE  `username` = 'admin' LIMIT 1 [ RunTime:0.102677s ]
---------------------------------------------------------------

[2020-03-11T13:44:14+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.136877s] [吞吐率：7.31req/s] [内存消耗：4,383.27kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T13:44:14+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.166874s] [吞吐率：5.99req/s] [内存消耗：4,255.53kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T13:44:19+08:00] ::1 GET localhost/tumor/public/index.php/admin/immunotherapy
[运行时间：0.645712s] [吞吐率：1.55req/s] [内存消耗：6,507.91kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immunotherapy',
  'route' => '@admin/immuno/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immuno\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.140442s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immunotherapy` [ RunTime:0.097086s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immunotherapy` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomaker` LIKE '%%'  OR `nccn_drug` LIKE '%%' ) [ RunTime:0.099853s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immunotherapy` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomaker` LIKE '%%'  OR `nccn_drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.116029s ]
---------------------------------------------------------------

[2020-03-11T13:45:27+08:00] ::1 GET localhost/tumor/public/index.php/admin/immunotherapy/1/edit
[运行时间：0.501978s] [吞吐率：1.99req/s] [内存消耗：6,282.91kb] [文件加载：83]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immunotherapy/<id>/edit',
  'route' => '@admin/immuno/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immunotherapy',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immuno\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.132666s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immunotherapy` [ RunTime:0.088459s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immunotherapy` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.089359s ]
---------------------------------------------------------------

[2020-03-11T13:58:07+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.166645s] [吞吐率：6.00req/s] [内存消耗：4,641.60kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T13:58:08+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.135523s] [吞吐率：7.38req/s] [内存消耗：4,259.20kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:05:51+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.164695s] [吞吐率：6.07req/s] [内存消耗：4,386.82kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:05:51+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.147531s] [吞吐率：6.78req/s] [内存消耗：4,259.20kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:05:53+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.147798s] [吞吐率：6.77req/s] [内存消耗：3,800.78kb] [文件加载：70]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immuno_other/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ error ] [0]类不存在:app\admin\controller\ImmunoOther[C:\wamp64\www\tumor\thinkphp\library\think\App.php:730]
---------------------------------------------------------------

[2020-03-11T14:07:24+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.145425s] [吞吐率：6.88req/s] [内存消耗：4,387.39kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:07:24+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.138129s] [吞吐率：7.24req/s] [内存消耗：4,259.97kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:07:26+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.602306s] [吞吐率：1.66req/s] [内存消耗：6,278.03kb] [文件加载：86]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.276672s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.089906s ]
[ error ] [10501]SQLSTATE[42S22]: Column not found: 1054 Unknown column 'biomaker' in 'where clause'[C:\wamp64\www\tumor\thinkphp\library\think\db\Connection.php:687]
---------------------------------------------------------------

[2020-03-11T14:09:21+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.158928s] [吞吐率：6.29req/s] [内存消耗：4,387.39kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:09:22+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.143246s] [吞吐率：6.98req/s] [内存消耗：4,259.97kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:09:23+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.466062s] [吞吐率：2.15req/s] [内存消耗：6,278.05kb] [文件加载：86]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.142911s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.101288s ]
[ error ] [10501]SQLSTATE[42S22]: Column not found: 1054 Unknown column 'biomaker' in 'where clause'[C:\wamp64\www\tumor\thinkphp\library\think\db\Connection.php:687]
---------------------------------------------------------------

[2020-03-11T14:11:22+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.158800s] [吞吐率：6.30req/s] [内存消耗：4,387.39kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:11:22+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.136109s] [吞吐率：7.35req/s] [内存消耗：4,259.97kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:11:24+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.588279s] [吞吐率：1.70req/s] [内存消耗：6,754.97kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.136639s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.091691s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.090436s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.092805s ]
---------------------------------------------------------------

[2020-03-11T14:12:18+08:00] ::1 GET localhost/tumor/public/index.php/admin/immunotherapy/1/edit
[运行时间：0.512160s] [吞吐率：1.95req/s] [内存消耗：6,287.67kb] [文件加载：83]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immunotherapy/<id>/edit',
  'route' => '@admin/immuno/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immuno\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.137706s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immunotherapy` [ RunTime:0.091679s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immunotherapy` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.092585s ]
---------------------------------------------------------------

[2020-03-11T14:29:48+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.159484s] [吞吐率：6.27req/s] [内存消耗：4,387.39kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:29:48+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.142498s] [吞吐率：7.02req/s] [内存消耗：4,259.97kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:29:51+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.621126s] [吞吐率：1.61req/s] [内存消耗：6,757.98kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.150270s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.099838s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.100074s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.101004s ]
---------------------------------------------------------------

[2020-03-11T14:29:53+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other/1/edit
[运行时间：0.502995s] [吞吐率：1.99req/s] [内存消耗：6,529.91kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>/edit',
  'route' => '@admin/immother/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.140490s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.094114s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.094151s ]
---------------------------------------------------------------

[2020-03-11T14:32:16+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.157236s] [吞吐率：6.36req/s] [内存消耗：4,387.39kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:32:16+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.138547s] [吞吐率：7.22req/s] [内存消耗：4,259.97kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:32:19+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.604449s] [吞吐率：1.65req/s] [内存消耗：6,489.17kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.141303s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.094622s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.096210s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.095618s ]
---------------------------------------------------------------

[2020-03-11T14:32:22+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other/1/edit
[运行时间：0.509946s] [吞吐率：1.96req/s] [内存消耗：6,531.43kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>/edit',
  'route' => '@admin/immother/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.134886s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.090847s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.091543s ]
---------------------------------------------------------------

[2020-03-11T14:32:53+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.162844s] [吞吐率：6.14req/s] [内存消耗：4,387.39kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:32:53+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.138169s] [吞吐率：7.24req/s] [内存消耗：4,259.97kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:32:55+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.649202s] [吞吐率：1.54req/s] [内存消耗：6,489.28kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.158703s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.106007s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.107762s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.106864s ]
---------------------------------------------------------------

[2020-03-11T14:32:57+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other/1/edit
[运行时间：0.490173s] [吞吐率：2.04req/s] [内存消耗：6,531.43kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>/edit',
  'route' => '@admin/immother/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.135520s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.090574s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.091789s ]
---------------------------------------------------------------

[2020-03-11T14:37:27+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.163426s] [吞吐率：6.12req/s] [内存消耗：4,387.39kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:37:27+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.136138s] [吞吐率：7.35req/s] [内存消耗：4,259.97kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:37:29+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.586014s] [吞吐率：1.71req/s] [内存消耗：6,494.06kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.138315s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.091064s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.090892s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.092155s ]
---------------------------------------------------------------

[2020-03-11T14:37:31+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other/1/edit
[运行时间：0.540196s] [吞吐率：1.85req/s] [内存消耗：6,536.21kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>/edit',
  'route' => '@admin/immother/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.152697s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.102209s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.102229s ]
---------------------------------------------------------------

[2020-03-11T14:37:37+08:00] ::1 PUT localhost/tumor/public/index.php/admin/immuno_other/1
[运行时间：0.481448s] [吞吐率：2.08req/s] [内存消耗：6,047.30kb] [文件加载：78]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>',
  'route' => '@admin/immother/update',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '1820',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other/1/edit',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'cancer_type' => '肺癌',
  'cancer_subtype' => '非小细胞aaaaaaa',
  'gene' => 'ALK',
  'variant_type' => '重排',
  'mutation_detail' => '一项开放标签Ⅱ期单臂临床试验表明，仅12.2%（95%CI5.7-21.8）携带ALK重排的NSCLC患者达到OR，显著低于ALK重排阴性组[PMID: 29545095]。有文献表明，在非小细胞肺癌中，ALK融合蛋白过表达可增加PD-L1的表达[PMID: 27141355]，然而大多数ALK重排NSCLC患者对PD-1/PD-L1抑制剂不响应，说明PD-1/PD-L1不是衡量免疫疗效的唯一指标。结合临床试验和科学文献，推断发生ALK重排突变可能与免疫疗法呈负相关。',
  'significance' => '携带ALK重排的NSCLC患者相比野生型患者对免疫抑制剂疗效响应较差。',
  'correlation' => '负相关',
  'biomarker' => 'ALK',
  'note' => 'LIO#LT',
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.132887s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.088408s ]
[ sql ] [ SQL ] UPDATE `tp_immuno_other`  SET `cancer_type` = '肺癌' , `cancer_subtype` = '非小细胞aaaaaaa' , `gene` = 'ALK' , `variant_type` = '重排' , `mutation_detail` = '一项开放标签Ⅱ期单臂临床试验表明，仅12.2%（95%CI5.7-21.8）携带ALK重排的NSCLC患者达到OR，显著低于ALK重排阴性组[PMID: 29545095]。有文献表明，在非小细胞肺癌中，ALK融合蛋白过表达可增加PD-L1的表达[PMID: 27141355]，然而大多数ALK重排NSCLC患者对PD-1/PD-L1抑制剂不响应，说明PD-1/PD-L1不是衡量免疫疗效的唯一指标。结合临床试验和科学文献，推断发生ALK重排突变可能与免疫疗法呈负相关。' , `significance` = '携带ALK重排的NSCLC患者相比野生型患者对免疫抑制剂疗效响应较差。' , `correlation` = '负相关' , `biomarker` = 'ALK' , `note` = 'LIO#LT'  WHERE  `id` = 1 [ RunTime:0.092560s ]
---------------------------------------------------------------

[2020-03-11T14:37:39+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.583222s] [吞吐率：1.71req/s] [内存消耗：6,494.48kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.138375s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.092880s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.092561s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.094021s ]
---------------------------------------------------------------

[2020-03-11T14:37:42+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other/1/edit
[运行时间：0.480224s] [吞吐率：2.08req/s] [内存消耗：6,270.52kb] [文件加载：83]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>/edit',
  'route' => '@admin/immother/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.132939s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.088202s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.089038s ]
---------------------------------------------------------------

[2020-03-11T14:37:48+08:00] ::1 PUT localhost/tumor/public/index.php/admin/immuno_other/1
[运行时间：0.462268s] [吞吐率：2.16req/s] [内存消耗：6,046.98kb] [文件加载：78]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>',
  'route' => '@admin/immother/update',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '1813',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other/1/edit',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'cancer_type' => '肺癌',
  'cancer_subtype' => '非小细胞',
  'gene' => 'ALK',
  'variant_type' => '重排',
  'mutation_detail' => '一项开放标签Ⅱ期单臂临床试验表明，仅12.2%（95%CI5.7-21.8）携带ALK重排的NSCLC患者达到OR，显著低于ALK重排阴性组[PMID: 29545095]。有文献表明，在非小细胞肺癌中，ALK融合蛋白过表达可增加PD-L1的表达[PMID: 27141355]，然而大多数ALK重排NSCLC患者对PD-1/PD-L1抑制剂不响应，说明PD-1/PD-L1不是衡量免疫疗效的唯一指标。结合临床试验和科学文献，推断发生ALK重排突变可能与免疫疗法呈负相关。',
  'significance' => '携带ALK重排的NSCLC患者相比野生型患者对免疫抑制剂疗效响应较差。',
  'correlation' => '负相关',
  'biomarker' => 'ALK',
  'note' => 'LIO#LT',
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.138375s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.093037s ]
[ sql ] [ SQL ] UPDATE `tp_immuno_other`  SET `cancer_type` = '肺癌' , `cancer_subtype` = '非小细胞' , `gene` = 'ALK' , `variant_type` = '重排' , `mutation_detail` = '一项开放标签Ⅱ期单臂临床试验表明，仅12.2%（95%CI5.7-21.8）携带ALK重排的NSCLC患者达到OR，显著低于ALK重排阴性组[PMID: 29545095]。有文献表明，在非小细胞肺癌中，ALK融合蛋白过表达可增加PD-L1的表达[PMID: 27141355]，然而大多数ALK重排NSCLC患者对PD-1/PD-L1抑制剂不响应，说明PD-1/PD-L1不是衡量免疫疗效的唯一指标。结合临床试验和科学文献，推断发生ALK重排突变可能与免疫疗法呈负相关。' , `significance` = '携带ALK重排的NSCLC患者相比野生型患者对免疫抑制剂疗效响应较差。' , `correlation` = '负相关' , `biomarker` = 'ALK' , `note` = 'LIO#LT'  WHERE  `id` = 1 [ RunTime:0.098627s ]
---------------------------------------------------------------

[2020-03-11T14:37:50+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.594234s] [吞吐率：1.68req/s] [内存消耗：6,494.41kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.140800s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.093373s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.096773s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.094419s ]
---------------------------------------------------------------

[2020-03-11T14:50:17+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.163436s] [吞吐率：6.12req/s] [内存消耗：4,398.81kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:50:17+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.133728s] [吞吐率：7.48req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:50:19+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.586232s] [吞吐率：1.71req/s] [内存消耗：6,796.23kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.136166s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.091928s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.091550s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.093256s ]
---------------------------------------------------------------

[2020-03-11T14:50:36+08:00] ::1 DELETE localhost/tumor/public/index.php/admin/immuno_other/1
[运行时间：0.475071s] [吞吐率：2.10req/s] [内存消耗：6,123.16kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>',
  'route' => '@admin/immother/delete',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'accept' => '*/*',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.146181s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.092071s ]
[ sql ] [ SQL ] DELETE FROM `tp_immuno_other` WHERE  `id` = 1 [ RunTime:0.094563s ]
---------------------------------------------------------------

[2020-03-11T14:50:40+08:00] ::1 DELETE localhost/tumor/public/index.php/admin/immuno_other/2
[运行时间：0.490374s] [吞吐率：2.04req/s] [内存消耗：6,123.09kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/<id>',
  'route' => '@admin/immother/delete',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '2',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'accept' => '*/*',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '2',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.157536s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.103424s ]
[ sql ] [ SQL ] DELETE FROM `tp_immuno_other` WHERE  `id` = 2 [ RunTime:0.104961s ]
---------------------------------------------------------------

[2020-03-11T14:50:55+08:00] ::1 POST localhost/tumor/public/index.php/admin/immuno_other/delAll
[运行时间：0.453327s] [吞吐率：2.21req/s] [内存消耗：6,100.92kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/delAll',
  'route' => '@admin/immother/delAll',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '25',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'ids' => '3,4,5,6,7,8',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.140329s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.093298s ]
[ sql ] [ SQL ] DELETE FROM `tp_immuno_other` WHERE  `id` IN (3,4,5,6,7,8) [ RunTime:0.097535s ]
---------------------------------------------------------------

[2020-03-11T14:50:59+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.647065s] [吞吐率：1.55req/s] [内存消耗：6,527.92kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.156382s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.105455s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.106965s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.106059s ]
---------------------------------------------------------------

[2020-03-11T14:52:21+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other?search=%E9%9D%9E
[运行时间：0.601957s] [吞吐率：1.66req/s] [内存消耗：6,504.23kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'search' => '非',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.142366s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.097105s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%非%' OR `cancer_subtype` LIKE '%非%'  OR `biomarker` LIKE '%非%'  OR `gene` LIKE '%非%'  OR `variant_type` LIKE '%非%' ) [ RunTime:0.096721s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%非%' OR `cancer_subtype` LIKE '%非%'  OR `biomarker` LIKE '%非%'  OR `gene` LIKE '%非%'  OR `variant_type` LIKE '%非%' ) LIMIT 0,8 [ RunTime:0.096780s ]
---------------------------------------------------------------

[2020-03-11T14:52:29+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other?search=
[运行时间：0.646686s] [吞吐率：1.55req/s] [内存消耗：6,527.81kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other?search=%E9%9D%9E',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'search' => '',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.158038s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.104349s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.105780s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.104793s ]
---------------------------------------------------------------

[2020-03-11T14:57:52+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.158685s] [吞吐率：6.30req/s] [内存消耗：4,398.81kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:57:52+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.142339s] [吞吐率：7.03req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T14:57:53+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.442578s] [吞吐率：2.26req/s] [内存消耗：6,299.20kb] [文件加载：86]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.136323s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ error ] [10501]SQLSTATE[42S02]: Base table or view not found: 1146 Table 'tp5.tp_immuno_other' doesn't exist[C:\wamp64\www\tumor\thinkphp\library\think\db\Connection.php:687]
---------------------------------------------------------------

[2020-03-11T15:00:32+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.154771s] [吞吐率：6.46req/s] [内存消耗：4,398.81kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:00:32+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.128215s] [吞吐率：7.80req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:00:34+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.591320s] [吞吐率：1.69req/s] [内存消耗：6,487.05kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.151013s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.092178s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.091701s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.091748s ]
---------------------------------------------------------------

[2020-03-11T15:00:41+08:00] ::1 POST localhost/tumor/public/index.php/admin/immunotherapy/upload
[运行时间：0.588216s] [吞吐率：1.70req/s] [内存消耗：10,161.80kb] [文件加载：122]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immunotherapy/upload',
  'route' => '@admin/immuno/upload',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '46805',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'multipart/form-data; boundary=----WebKitFormBoundaryTSxffxN3CChI150W',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
---------------------------------------------------------------

[2020-03-11T15:00:56+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.306093s] [吞吐率：3.27req/s] [内存消耗：4,398.81kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:00:56+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.275610s] [吞吐率：3.63req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:00:57+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.716863s] [吞吐率：1.39req/s] [内存消耗：6,486.88kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.139844s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.093556s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.095135s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.097439s ]
---------------------------------------------------------------

[2020-03-11T15:01:02+08:00] ::1 POST localhost/tumor/public/index.php/admin/immunotherapy/upload
[运行时间：0.528590s] [吞吐率：1.89req/s] [内存消耗：10,162.09kb] [文件加载：122]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immunotherapy/upload',
  'route' => '@admin/immuno/upload',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '46805',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'multipart/form-data; boundary=----WebKitFormBoundary5AIsHVPAaOAqBiTz',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
---------------------------------------------------------------

[2020-03-11T15:01:05+08:00] ::1 GET localhost/tumor/public/static/admin/css/bootstrap.min.css.map
[运行时间：0.158163s] [吞吐率：6.32req/s] [内存消耗：2,936.23kb] [文件加载：59]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
---------------------------------------------------------------

[2020-03-11T15:01:44+08:00] ::1 POST localhost/tumor/public/index.php/admin/immunotherapy/upload
[运行时间：0.668383s] [吞吐率：1.50req/s] [内存消耗：10,162.09kb] [文件加载：122]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immunotherapy/upload',
  'route' => '@admin/immuno/upload',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '46805',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'multipart/form-data; boundary=----WebKitFormBoundarypLBQSspwTzy6C4m3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
---------------------------------------------------------------

[2020-03-11T15:01:54+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.451196s] [吞吐率：2.22req/s] [内存消耗：4,398.81kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:01:54+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.402027s] [吞吐率：2.49req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:01:58+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.892129s] [吞吐率：1.12req/s] [内存消耗：6,752.98kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.157431s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.106219s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.108411s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.106327s ]
---------------------------------------------------------------

[2020-03-11T15:01:59+08:00] ::1 GET localhost/tumor/public/static/admin/css/bootstrap.min.css.map
[运行时间：0.237896s] [吞吐率：4.20req/s] [内存消耗：2,936.23kb] [文件加载：59]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
---------------------------------------------------------------

[2020-03-11T15:02:03+08:00] ::1 POST localhost/tumor/public/index.php/admin/immuno_other/upload
[运行时间：1.132570s] [吞吐率：0.88req/s] [内存消耗：12,544.86kb] [文件加载：127]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other/upload',
  'route' => '@admin/immother/upload',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '46805',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'multipart/form-data; boundary=----WebKitFormBoundaryQLWK8sxiwcHM35cJ',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.137685s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.094158s ]
[ sql ] [ SQL ] INSERT INTO `tp_immuno_other` (`cancer_type` , `cancer_subtype` , `gene` , `variant_type` , `mutation_detail` , `significance` , `correlation` , `biomarker` , `note`) VALUES ( '肺癌','非小细胞','ALK','重排','一项开放标签Ⅱ期单臂临床试验表明，仅12.2%（95%CI5.7-21.8）携带ALK重排的NSCLC患者达到OR，显著低于ALK重排阴性组[PMID: 29545095]。有文献表明，在非小细胞肺癌中，ALK融合蛋白过表达可增加PD-L1的表达[PMID: 27141355]，然而大多数ALK重排NSCLC患者对PD-1/PD-L1抑制剂不响应，说明PD-1/PD-L1不是衡量免疫疗效的唯一指标。结合临床试验和科学文献，推断发生ALK重排突变可能与免疫疗法呈负相关。','携带ALK重排的NSCLC患者相比野生型患者对免疫抑制剂疗效响应较差。','负相关','ALK','LIO#LT' ) , ( '肺癌','非小细胞','EGFR','NA','EGFR变异可能与非小细胞肺癌免疫治疗超进展有关，一项临床研究中显示，携带EGFR变异可能与不良预后以及较短的超进展时间有关[PMID: 28351930]。','可能与EGFR突变患者的TMB以及PD1表达低相关。','负相关','EGFR','LIO#LT' ) , ( '肺癌','非小细胞','KRAS','NA','KRAS,原癌基因,哺乳动物 ras 基因家族成员，编码的蛋白为小 GTP 酶超家族成员，调节细胞信号转导通路。在肺腺癌中，约 15%-25%的患者存在 KRAS 突变，KRAS突变导致DNA修复缺陷，包括MMR、核苷酸切除修复(NER)、碱基切除修复(BER)等，大大增强了点突变，研究显示携带KRAS突变，免疫抑制剂治疗可能获益。[PMID: 29773717，PMID: 26477306 ，PMID: 28039262 ]','KRAS突变影响DNA复制及修复：突变负荷增加。','正相关','KRAS','LIO#LT' ) , ( '肺癌','非小细胞','MDM2/4','扩增','MDM2/4扩增可能与非小细胞肺癌免疫治疗超进展有关，一项临床研究中显示，携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，1例同时携带KIF5B-RET融合与MDM2扩增的肺腺癌患者在紫杉醇改为帕博利珠单抗治疗后第九天，出现超进展症状（严重疲劳、癌转移加快）；另一同时携带MDM2扩增与CDK4扩增的肺腺癌患者在帕博利珠单抗治疗1.5月后出现脑转移[PMID: 28351930]。','临床研究表明，携带该基因突变免疫用药可能导致超进展。','负相关','MDM2/4','LIO#LT' ) , ( '肺癌','非小细胞','POLE','NA','POLE基因与DNA修复相关，非小细胞肺癌患者对免疫抑制剂治疗的疗效与特定DNA修复突变有关。在三名对帕博丽珠单抗响应/敏感的肺癌患者中，发现了POLD1、POLE和MSH2致病突变，并且这些患者的突变负荷均较高，说明POLE突变的非小细胞肺癌患者可能对免疫抑制剂敏感[PMID:25765070]。','为DDR通路基因，突变使TMB显著升高，TNB升高。','正相关','POLE/POLD1','LIO#LT' ) , ( '肺癌','非小细胞','STK11','NA','LKB1基因（也称为STK11）编码了丝氨酸/苏氨酸激酶11。该酶是肿瘤抑制基因，它有助于防止细胞生长和分裂过快或以不受控制的方式分裂。这种酶帮助某些细胞在组织内正确地定向自身（极化），并帮助确定细胞的耗能。这种激酶还促进细胞凋亡（一种程序性细胞死亡过程）。LKB1突变可以负性调控PD-L1的表达并减少CD8T细胞的浸润。在LKB1突变失活的非小细胞肺癌中，PD-L1阻断治疗效果不明显，阻断IL-6可以获得较好的治疗效果。研究显示携带STK11基因突变，免疫抑制剂疗效可能不佳。[PMID: 26477306 ，PMID: 28039262 ]','STK11基因突变会让肿瘤细胞PD-L1表达低，免疫疗效不佳。','负相关','STK11','LIO#LT' ) , ( '肺癌','非小细胞','TP53','NA','TP53基因编码了肿瘤蛋白p53。这种蛋白质是肿瘤抑制因子，它防止细胞生长太快或以不受控制的方式分裂。TP53突变主要导致细胞周期和DNA复制的加速，这可能增加了突变的可能性，因为未修复的DNA损伤不会通过阻断复制而杀死细胞，往往会导致复制错误，从而导致突变，在肺腺癌中，TP53 突变显著增加了免疫检查点表达，产生更高的突变负荷，并激活了 T 效应细胞和 IFN-γ，研究显示携带TP53突变，免疫抑制剂治疗可能获益。（PMID: 26477306 ，PMID: 28039262 ）','TP53突变影响DNA复制及修复：突变负荷增加。','正相关','TP53','LIO#LT' ) , ( '肺癌','非小细胞','KRAS#TP53','NA','受检者携带KRAS和TP53共突变，研究证明TP53 或 KRAS 突变的非小细胞肺癌相比野生型的肿瘤表达更高水平的 PD-L1 蛋白。研究分析了 165 位 KRAS 突变的肺腺癌，分为携带 KRAS 和 LKB1 突变的患者（KL）、携带 KRAS 和 TP53 突变患者（KP）和只携带 KRAS 突变（K-only ）三组，KP组疗效最佳，显示携带KRAS、TP53共突变，免疫抑制剂治疗获益。[PMID: 29773717]','NA','NA','KRAS&TP53','LIO#LT' ) , ( '肺癌','非小细胞','KRAS#STK11','NA','受检者携带KRAS和STK11共突变，研究分析 KRAS 突变的肺腺癌，分为携带 KRAS 和 LKB1 突变的患者（KL）、携带 KRAS 和 TP53 突变患者（KP）和只携带 KRAS 突变（K-only ）三组，结果KL组对PD-1抑制剂的耐药率最高，显示携带KRAS、STK11共突变，免疫抑制剂疗效可能不佳。[PMID: 29773717]','NA','NA','KRAS&STK11','LIO#LT' ) , ( '肺癌','非小细胞','TP53#STK11','NA','受检者携带TP53和STK11共突变，STK11&TP53共突变为罕见突变，尚无研究明确TP53和STK11共突变，免疫抑制剂疗效的情况，而研究显示STK11基因与抑制免疫监视反应密切相关，免疫抑制剂疗效不佳，且其与KRAS共突变显示PD-1抑制剂的耐药率最高，故推测TP53和STK11共突变，免疫抑制剂疗效不佳[PMID: 29773717]','NA','NA','TP53&STK11','LIO#LT' ) , ( '肺癌','非小细胞','POLD1','NA','POLD1往往与POLE发生共突变，POLD1基因与DNA修复相关，非小细胞肺癌患者对免疫抑制剂治疗的疗效与特定DNA修复突变有关。在三名对帕博丽珠单抗响应/敏感的肺癌患者中，发现了POLD1、POLE和MSH2致病突变。其中一名无吸烟史但对药物持续响应的患者中发现了POLD1 E374K突变，且该患者的非同义突变负荷是该研究中所有无吸烟史患者中最高。在另一名药物响应者中，发现携带POLD1 C284Y突变，且该患者在该系列中有着最大的突变负荷[PMID:25765070]。说明POLD1突变可能与高突变负荷以及对免疫抑制剂疗效较好相关。','为DDR通路基因，突变使TMB显著升高，TNB升高。','正相关','POLE/POLD1','LIO#LT' ) , ( '黑色素瘤','NA','B2M','NA','B2M缺失可能是CTLA4 或PD1靶向治疗发生耐药的常见机制，当B2M失活突变，抗原呈递功能受损，免疫疗效不佳。研究对17例接受过免疫检查点抑制疗法的转移性黑色素瘤患者的肿瘤活检标本进行了分析。29.4%的进展性疾病患者中观察到了ß2微球蛋白（B2M）中杂合子（LOH）的缺失（deletions or loss），以及点突变。在2项相互独立的抗CTLA4和抗PD1疗法的转移性黑色素瘤患者队列中，研究人员发现无缓解患者中B2M LOH富集是缓解患者中的3倍（~30%vs~10%），并与较差的总生存相关（log-rank p=0.01, p = 0.006）。（PMID: 29070816）','缺少B2M部分，抗原分子不能表达在细胞表面，MHC I类分子多样性降低。','负相关','B2M','LIO#LT' ) , ( '黑色素瘤','NA','BRCA2','NA','一项通过研究黑色素瘤病人在抗PD-1免疫疗法治疗过程中的体细胞基因组学和转录组学特征，结果表明在产生高治疗应答效应的病人肿瘤组织中存在DNA修复基因BRCA2的突变富集情况，即BRCA2突变富集型黑素瘤对抗PD-1有响应。BRCA2 LOF突变预计会在同源重组和双链DNA断裂修复中产生缺陷（Holloman，2011），可能产生特异性突变特征或未知影响（如诱导细胞死亡），这有助于抗PD-1响应。','在对免疫治疗有响应的黑色素瘤患者中观察到BRCA2的功能缺失性突变。','正相关','BRCA2','LIO#LT' ) , ( '黑色素瘤','NA','DNMT3A','NA','DNMT3A变异可能与黑色素瘤免疫治疗超进展有关，一项临床研究中显示，携带DNMT3A变异可能与不良预后以及较短的超进展时间有关，TTF<2个月[PMID: 28351930]。','携带DNMT3A变异可能与不良预后以及较短的超进展时间有关，TTF<2个月。','负相关','DNMT3A','LIO#LT' ) , ( '黑色素瘤','NA','EGFR','NA','EGFR变异可能与黑色素瘤免疫治疗超进展有关，一项临床研究中显示，携带EGFR变异可能与不良预后以及较短的超进展时间有关，TTF<2个月[PMID: 28351930]。','携带EGFR变异可能与不良预后以及较短的超进展时间有关，TTF<2个月。','负相关','EGFR','LIO#LT' ) , ( '黑色素瘤','NA','JAK1/2','NA','JAK1/2功能失活性突变可导致PD-1阻断治疗获得性耐药，即使患者具有较高的突变符合，但携带JAK1/2突变的患者对PD-L1阻断治疗没有响应且预后不良。JAK1/2功能失活突变是由PD-L1表达缺失γ干扰素无响应的基因机制，从而导致对PD-1阻断治疗原发性耐药[PMID:27433843、27903500]。','JAK1/2突变与肿瘤细胞不受IFN-gamma引起的生长抑制有关。','负相关','JAK1/2','LIO#LT' ) , ( '黑色素瘤','NA','MDM2/4','扩增','可能与黑色素瘤免疫治疗超进展有关，一项临床研究中显示，携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，TTF<2个月[PMID: 28351930]。','携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，TTF<2个月。','负相关','MDM2/4','LIO#LT' ) , ( '黑色素瘤','NA','PTEN','NA','无论在黑色素瘤的临床前试验（细胞/动物模型）还是临床试验中，PTEN丢失都会抑制T细胞介导的肿瘤杀伤和浸润。在临床试验中PTEN丢失也与PD-1抑制剂疗效减弱有关：携带PTEN丢失的黑色素瘤患者在接受抗PD-1抗体（帕博丽珠单抗和纳武利尤单抗）治疗时，肿瘤大小的减少显著劣于PTEN野生型的患者[PMID：26645196]','在PTEN缺失的黑色素瘤细胞中，细胞因子分泌减少导致不能有效招募足够的TIL，CD8+T细胞减少。','负相关','PTEN','LIO#LT' ) , ( '黑色素瘤','NA','TP53','NA','研究分析110例使用ipilimumab治疗的黑色素瘤患者的全外显子和临床数据，分析显示野生型TP53患者和突变型TP53患者的客观反应率和长期受益率分别为35%和10%，TP53突变型PFS，OS均较差。进一步探讨黑色素瘤中TP53与免疫相关基因标志物的关系，发现TP53突变与抗ctla -4在黑色素瘤中的不良预后之间的关系可能是由于FAS表达水平被TP53突变下调，阻碍了ctl介导的肿瘤细胞凋亡。TP53突变可能是抗ctla -4治疗转移性黑色素瘤的负性预测因子，仍需进一步研究。（DOI: 10.1016/j.ebiom.2018.05.019）','TP53突变与抗ctla -4在黑色素瘤中的不良预后有关。','负相关','TP53','LIO#LT' ) , ( '黑色素瘤','NA','PBRM1/ARID2','NA','有文献表明，PBRM1/ARID2的表达与细胞毒性T细胞的呈负相关，在CD8 T细胞高表达的黑色素瘤中，携带低ARID2的mRNA水平的患者更有实在的生存获益。因此携带PBRM1/ARID2突变失活的肿瘤对PD-1抑制剂以及以细胞毒性T细胞为主要效应机制的免疫疗法更敏感[PMID: 29301958]。','PBRM1/ARID2功能缺失突变对于肾癌和黑色素瘤患者，能够增加肿瘤细胞对于免疫细胞毒性的敏感性，并对IFN引起的效应响应更强。','正相关','PBRM1/ARID2','LIO#LT' ) , ( '黑色素瘤','NA','HLA','NA','已有多个研究证实HLA单个或多个基因的缺失以及HLA中I类抗原表达丢失会导致黑色素瘤细胞的免疫原性被改变[PMID:1898655，12516095，15905528，16622680]。在对一名黑色素瘤患者的原发和转移灶进行研究时，发现B2M基因的失活突变以及15q染色体的丢失会导致HLA的I类抗原呈阴性，从而在转移过程中黑色素瘤免疫原性丧失而产生对T细胞的抗性，可能是临床上黑色素瘤患者对T细胞为基础的免疫治疗产生抗性的原因[PMID:25294904]。也就是说，HLA功能的丧失可能与T细胞为基础的免疫治疗耐药有关。','HLA失活突变，抗原呈递功能受损，免疫疗效不佳。','负相关','HLA','LIO#LT' ) , ( '结直肠癌','NA','POLE','NA','携带POLE突变的结直肠癌患者往往会同时出现高突变负荷（TMB/TNB），免疫抑制剂疗效较好。在一项病例分析中，一名81岁的结肠腺癌患者检出POLE V411L突变，且该患者的MSI状态是MSS，组织TMB检出122mut/Mb（高突变负荷）。在前期化疗过程中发生进展，而在接受帕博丽珠单抗治疗后，患者疲劳的状态缓解，肿瘤标志物CEA水平下降[PMID：28188185]。并且在多个研究中已有报道携带POLE突变的结直肠癌患者预后更佳，且一般不会与MSI-H同时发生[PMID:28404093，27022117]。','为DDR通路基因，突变使TMB显著升高，TNB升高。','正相关','POLE/POLD1','LIO#LT' ) , ( '结直肠癌','NA','JAK1/2','NA','有研究显示，JAK功能失活突变可使结直肠癌患者对PD-1阻断治疗原发性耐药，即使患者具有较高的突变负荷，但是对PD-1阻断治疗没有反应，且预后不良[PMID: 27903500]。','JAK功能失活突变可使结直肠癌患者对PD-1阻断治疗原发性耐药。','负相关','JAK1/2','LIO#LT' ) , ( '尿路上皮癌','NA','DDR','NA','DNA损伤修复（DDR，DNA Damage Repair ）基因。一项临床研究发现，针对晚期转移性尿路上皮癌患者，携带DDR基因有害突变的患者更易从PD-1/PD-L1抑制剂（纳武单抗或阿特珠单抗）治疗中获益，且比DDR基因野生型患者的无进展生存期更长。（PMID: 29489427）','突变使TMB显著升高，对免疫治疗响应较好。','正相关','DDR','LIO#LT' ) , ( '膀胱癌','NA','MDM2/4','扩增','可能与膀胱癌免疫治疗超进展有关，一项临床研究中显示，携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，1例携带MDM2扩增的膀胱癌患者在接受阿特珠单抗治疗1.9个月后出现肝转移、体重减轻、发烧等症状[PMID: 28351930]。','临床研究表明，携带该基因突变免疫用药可能导致超进展。','负相关','MDM2/4','LIO#LT' ) , ( '皮肤癌','鳞状','EGFR','NA','EGFR变异可能与鳞状细胞皮肤癌免疫治疗超进展有关，一项临床研究中显示，携带EGFR变异可能与不良预后以及较短的超进展时间有关，TTF<2个月[PMID: 28351930]。','携带EGFR变异可能与不良预后以及较短的超进展时间有关，TTF<2个月。','负相关','EGFR','LIO#LT' ) , ( '皮肤癌','鳞状','MDM2/4','扩增','可能与鳞状细胞皮肤癌免疫治疗超进展有关，一项临床研究中显示，携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，TTF<2个月[PMID: 28351930]。','携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，TTF<2个月。','负相关','MDM2/4','LIO#LT' ) , ( '皮肤癌','鳞状','DNMT3A','NA','DNMT3A变异可能与鳞状细胞皮肤癌免疫治疗超进展有关，一项临床研究中显示，携带DNMT3A变异可能与不良预后以及较短的超进展时间有关，TTF<2个月[PMID: 28351930]。','携带DNMT3A变异可能与不良预后以及较短的超进展时间有关，TTF<2个月。','负相关','DNMT3A','LIO#LT' ) , ( '乳腺癌','三阴性','MDM2/4','扩增','可能与乳腺癌免疫治疗超进展有关，一项临床研究中显示，携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，1例携带MDM2扩增的三阴性乳腺癌患者在接受帕博利珠单抗治疗1.5个月后出现左肺和胸膜肿物，以及淋巴肿大[PMID: 28351930]。','临床研究表明，携带该基因突变免疫用药可能导致超进展。','负相关','MDM2/4','LIO#LT' ) , ( '子宫内膜癌','NA','POLE','NA','POLE基因与DNA修复相关，发生POLE突变的子宫内膜癌患者往往同时表现出高的突变负荷（TMB/TNB），往往与较好的免疫抑制剂疗效相关。在对252名子宫内膜癌患者进行基因分析发现有9.1%患者也检出POLE突变，同时TCGA数据库中，有10%子宫内膜癌患者携带POLE突变，且非同义突变负荷高于未携带该突变的患者。而且携带POLE突变的患者一般会表达更高水平的免疫相关蛋白。[PMID:27159395，25878334]。','为DDR通路基因，突变使TMB显著升高，TNB升高。','正相关','POLE/POLD1','LIO#LT' ) , ( '卵巢癌','NA','DDR','NA','2018年ASCO大会上公布的关于DDR与TMB在卵巢癌中的相关结果指出，DDR变异的卵巢癌患者表现出更高的基因组不稳定性，与TMB升高显著相关，可能对免疫治疗更为敏感。其中纳入研究的TCGA cohort 434例卵巢癌患者主要为白种人，组织学类型均为浆液性卵巢癌；3DMedicines公司（3D Med）92例卵巢癌Clinical cohort均为中国人，组织学类型以浆液性卵巢癌为主（82.6%）。研究结果显示相比于DDR基因野生型，携带任意1个或2个DDR基因变异与高TMB显著相关。TP53和任意1个DDR基因共突变与高TMB显著相关。高TMB与显著延长的OS (49.2个月对41个月， HR=0.77，P=0.037) 相关。此外，携带和不携带DDR基因变异中位PFS分别为19.2个月和16.7个月 (P = 0.07)，mOS 分别为54.6个月和41.5个月 (P = 0.02)。本研究中，无论是TCGA cohort还是Clinical cohort，DDR变异均与TMB升高显著相关；此外，在TCGA cohort中，DDR变异或者TMB高的卵巢癌患者具有更好的预后。','突变使TMB显著升高，对免疫治疗响应较好。','正相关','DDR','LIO#LT' ) , ( '头颈部肿瘤','鳞状','EGFR','NA','EGFR 抑制剂可以增强抗PD-1免疫治疗的效果，可作为肿瘤免疫治疗的一个靶点。EGFR抑制剂厄洛替尼可以放大T细胞的杀伤力。一项回顾性研究中，41例复发/转移的头颈部鳞状细胞癌（SCCHN）患者接受了阿法替尼和PD-1抗体帕博利珠单抗的联合治疗，组合治疗的总体反应率（ORR）为58.5％，平均肿瘤大小减少82.9％，毒副作用未增加。相比于帕博利珠单抗单药治疗的ORR 16％和阿法替尼单药治疗的10％，这些临床观察结果证明了EGFR抑制剂与抗PD-1抑制剂的协同作用[PMID: 30242021]。','EGFR 抑制剂可以增强抗PD-1免疫治疗的效果。','负相关','EGFR','LIO#LT' ) , ( '肾癌','NA','PBRM1/ARID2','NA','PBRM1功能失活性突变与免疫治疗临床获益有关，可预示良好预后。一项35例转移性透明细胞肾癌（ccRCC）的临床试验中，经过纳武单抗治疗后，临床获益的患者携带PBRM1的比例要比临床未获益的患者高（9/11 vs. 3/13）；并且在63位患者的后续验证性临床研究中，经PD-(L)1抑制剂单独治疗或联合CTLA-4抑制剂治疗后，临床获益的患者携带PBRM1的比例要仍比临床未获益的患者高（17/27 vs. 4/19）[PMID：29301960]；与此类似，另一项24例转移性肾细胞癌的临床研究也显示携带PBRM1突变的患者对Ipilimumab更敏感[PMID：30591082]。其可能的信号通路是SWI/SNF[PMID：29301960]。','PBRM1/ARID2功能缺失突变对于肾癌和黑色素瘤患者，能够增加肿瘤细胞对于免疫细胞毒性的敏感性，并对IFN引起的效应响应更强。','正相关','PBRM1/ARID2','LIO#LT' ) , ( '癌种未区分','NA','TNB','TNB-H','受检者检测到TNB-H，表示肿瘤新抗原负荷较高，而高肿瘤突变负荷的肿瘤有更多的肿瘤抗原呈递，更有可能从免疫检查点抑制剂治疗中获益。但TNB目前暂未写入指南，也未获得FDA批准用药。','肿瘤新抗原越多，T细胞反应和抗肿瘤反应越强，免疫疗效越好。（肿瘤新生抗原负荷高是PD-1/L1抗体有效的基本条件之一）。','正相关','TNB','LIO#LT' ) , ( '癌种未区分','NA','MLH1','NA','受检者检测到MLH1基因突变，MLH1基因属于错配修复基因（MMR）中的一种，该基因的功能丧失型突变会导致错配修复基因产生缺陷（dMMR），往往会导致MSI水平升高（MSI-H），提示对免疫抑制剂敏感性增高。','DNA错配修复基因，FDA批准Pembrolizumab用于MSI-H（或dMMR）的实体瘤患者，批准Nivolumab用于不可切除或转移性的MSI-H (或dMMR)的结直肠癌患者。','正相关','MLH1','LIO#LT' ) , ( '癌种未区分','NA','MSH2','NA','受检者检测到MSH2基因突变，MSH2基因属于错配修复基因（MMR）中的一种，该基因的功能丧失型突变会导致错配修复基因产生缺陷（dMMR），往往会导致MSI水平升高（MSI-H），提示对免疫抑制剂敏感性增高。','NA','正相关','MSH2','LIO#LT' ) , ( '癌种未区分','NA','MSH6','NA','受检者检测到MSH6基因突变，MSH6基因属于错配修复基因（MMR）中的一种，该基因的功能丧失型突变会导致错配修复基因产生缺陷（dMMR），往往会导致MSI水平升高（MSI-H），提示对免疫抑制剂敏感性增高。','NA','正相关','MSH6','LIO#LT' ) , ( '癌种未区分','NA','PMS2','NA','受检者检测到PMS2基因突变，PMS2基因属于错配修复基因（MMR）中的一种，该基因的功能丧失型突变会导致错配修复基因产生缺陷（dMMR），往往会导致MSI水平升高（MSI-H），提示对免疫抑制剂敏感性增高。','NA','正相关','PMS2','LIO#LT' ) , ( '癌种未区分','NA','ALK','重排','有研究表明，ALK融合突变的非小细胞肺癌患者免疫疗效不佳[PMID: 27141355]，但在该癌种分型中暂无相关充分证据证明ALK基因突变的影响。','携带ALK重排的NSCLC患者相比野生型患者对免疫抑制剂疗效响应较差。','负相关','ALK','LIO#LT' ) , ( '癌种未区分','NA','EGFR','NA','EGFR突变可能与非小细胞肺癌、黑色素瘤、皮肤鳞状细胞癌和头颈部鳞状细胞癌免疫治疗超进展有关[PMID: 28351930，30242021，28351930]，但在该癌种分型中尚无充分的证据证明EGFR突变与免疫治疗的效果关系。','可能与EGFR突变患者的TMB以及PD1表达低相关。','负相关','EGFR','LIO#LT' ) , ( '癌种未区分','NA','KRAS','NA','研究显示携带KRAS突变的非小细胞肺癌患者对免疫抑制剂治疗更能获益[PMID: 29773717，26477306，28039262]，但在该癌种分型中暂无相关证据证明该变异与免疫治疗疗效相关性。','KRAS突变影响DNA复制及修复：突变负荷增加。','正相关','KRAS','LIO#LT' ) , ( '癌种未区分','NA','MDM2/4','扩增','MDM2/4扩增突变与非小细胞肺癌、黑色素瘤、膀胱癌（包括尿路上皮癌）、皮肤鳞状细胞癌和三阴性乳腺癌免疫治疗超进展有关[PMID: 28351930]，但在该癌种分型中尚无相关充分证据证明与该变异的相关性。','临床研究表明，携带该基因突变免疫用药可能导致超进展。','负相关','MDM2/4','LIO#LT' ) , ( '癌种未区分','NA','POLE','NA','携带POLE突变的非小细胞肺癌、结直肠癌、子宫内膜癌患者可能对免疫抑制剂更敏感[PMID:25765070，28404093，27022117，27159395，25878334]，但在该癌种分型中无足够证据证明该基因突变与该癌种的相关性。','为DDR通路基因，突变使TMB显著升高，TNB升高。','正相关','POLE/POLD1','LIO#LT' ) , ( '癌种未区分','NA','STK11','NA','携带STK11基因突变可能会使非小细胞肺癌患者免疫抑制剂疗效不佳[PMID: 26477306 ，PMID: 28039262 ]，但在该癌种分型中暂无相关证据证明该变异与免疫治疗的关系。','STK11基因突变会让肿瘤细胞PD-L1表达低，免疫疗效不佳。','负相关','STK11','LIO#LT' ) , ( '癌种未区分','NA','TP53','NA','在非小细胞肺癌中，TP53突变显著增加了免疫检查点表达，产生更高的突变负荷并激活免疫细胞，对免疫抑制剂治疗可能获益。在黑色素瘤中，TP53突变与抗ctla -4在黑色素瘤中的不良预后有关[PMID: 26477306 ，28039262 ]。但在该癌种分型中尚无相关证明该突变与免疫疗效关系。','TP53突变影响DNA复制及修复：突变负荷增加。','正相关','TP53','LIO#LT' ) , ( '癌种未区分','NA','POLD1','NA','有研究表明，在非小细胞肺癌中携带POLD1突变有较大的突变负荷，对免疫抑制剂疗效较好相关。但在该癌种分型中尚无充分证据证明该突变与免疫疗法的相关性。','为DDR通路基因，突变使TMB显著升高，TNB升高。','正相关','POLE/POLD1','LIO#LT' ) , ( '癌种未区分','NA','B2M','NA','有研究表明，黑色素瘤中当B2M失活突变，抗原呈递功能受损，导致免疫疗效不佳[PMID: 29070816]。但在该癌种中尚无充分证据证明该突变与免疫疗法的相关性。','缺少B2M部分，抗原分子不能表达在细胞表面，MHC I类分子多样性降低。','负相关','B2M','LIO#LT' ) , ( '癌种未区分','NA','BRCA2','NA','一项对黑色素瘤患者进行免疫疗法的研究表明，BRCA2突变富集型黑素瘤对抗PD-1有响应。但在该癌种中尚无充分证据证明该突变与免疫疗法的相关性。','在对免疫治疗有响应的黑色素瘤患者中观察到BRCA2的功能缺失性突变。','正相关','BRCA2','LIO#LT' ) , ( '癌种未区分','NA','DNMT3A','NA','针对黑色素瘤和皮肤鳞状细胞癌的临床研究中显示，携带DNMT3A变异可能与不良预后以及较短的超进展时间有关[PMID: 28351930]。但在该癌种分型中尚无充分证据证明该突变与免疫疗法的相关性。','携带DNMT3A变异可能与不良预后以及较短的超进展时间有关，TTF<2个月。','负相关','DNMT3A','LIO#LT' ) , ( '癌种未区分','NA','DDR','NA','携带DDR基因有害突变的转移性尿路上皮癌和卵巢癌患者更易从PD-1/PD-L1抑制剂治疗中获益[PMID: 29489427]。但在该癌种中尚无充分证据证明该突变与免疫疗法的相关性。','突变使TMB显著升高，对免疫治疗响应较好。','正相关','DDR','LIO#LT' ) , ( '癌种未区分','NA','PBRM1/ARID2','NA','针对透明细胞肾癌的临床试验表明，携带PBRM1/ARID2突变的患者从免疫疗法获益更大[PMID：29301960,30591082,29301960]。但在该癌种中尚无充分证据证明该突变与免疫疗法的相关性。','PBRM1/ARID2功能缺失突变对于肾癌和黑色素瘤患者，能够增加肿瘤细胞对于免疫细胞毒性的敏感性，并对IFN引起的效应响应更强。','正相关','PBRM1/ARID2','LIO#LT' ) , ( '癌种未区分','NA','HLA','NA','已有多个研究证实HLA单个或多个基因的缺失以及HLA中I类抗原表达丢失会导致黑色素瘤细胞的免疫原性被改变[PMID:1898655，12516095，15905528，16622680]。HLA功能失活可能会使黑色素瘤免疫原性丧失而产生对T细胞的抗性，对T细胞为基础的免疫治疗耐药[PMID:25294904]。但在该癌种中尚无相关研究表明HLA失活与免疫治疗相关。','HLA失活突变，抗原呈递功能受损，免疫疗效不佳。','负相关','HLA','LIO#LT' ) , ( '癌种未区分','NA','JAK1/2','NA','JAK1/2功能失活性突变可导致黑色素瘤和结直肠癌患者对PD-1阻断治疗原发性耐药，对PD-1阻断治疗没有反应，且预后不良[PMID:27433843、27903500]。但在该癌种中尚无相关研究表明该突变与免疫治疗关系。','JAK功能失活突变可使结直肠癌患者对PD-1阻断治疗原发性耐药。','负相关','JAK1/2','LIO#LT' ) , ( '癌种未区分','NA','PTEN','NA','在对黑色素瘤的非临床试验和临床试验研究表明，PTEN丢失导致T细胞介导的肿瘤杀伤和浸润的抑制，使免疫治疗效果减弱。但在该癌种中尚无相关研究表明该突变与免疫治疗关系。','在PTEN缺失的黑色素瘤细胞中，细胞因子分泌减少导致不能有效招募足够的TIL，CD8+T细胞减少。','负相关','PTEN','LIO#LT' ) , ( '尿路上皮癌','NA','MDM2/4','扩增','可能与膀胱癌（包括尿路上皮癌）免疫治疗超进展有关，一项临床研究中显示，携带MDM2/4变异可能与不良预后以及较短的超进展时间有关，1例携带MDM2扩增的膀胱癌患者在接受阿特珠单抗治疗1.9个月后出现肝转移、体重减轻、发烧等症状[PMID: 28351930]。','临床研究表明，携带该基因突变免疫用药可能导致超进展。','负相关','MDM2/4','LIO#LT' ) , ( '癌种未区分','NA','TP53#STK11','NA','受检者携带TP53和STK11共突变，STK11&TP53共突变为罕见突变，尚无研究明确TP53和STK11共突变，免疫抑制剂疗效的情况，而研究显示STK11基因与抑制免疫监视反应密切相关，免疫抑制剂疗效不佳，且其与KRAS共突变显示PD-1抑制剂的耐药率最高，故推测TP53和STK11共突变，免疫抑制剂疗效不佳[PMID: 29773717]。但在该癌种分型中尚无相关证明该突变与免疫疗效关系。','NA','负相关','TP53#STK11','LT&LIO' ) [ RunTime:0.161806s ]
---------------------------------------------------------------

[2020-03-11T15:02:04+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.847117s] [吞吐率：1.18req/s] [内存消耗：6,528.04kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/immuno_other',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.185533s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.088645s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.089369s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.089648s ]
---------------------------------------------------------------

[2020-03-11T15:02:05+08:00] ::1 GET localhost/tumor/public/static/admin/css/bootstrap.min.css.map
[运行时间：0.245216s] [吞吐率：4.08req/s] [内存消耗：2,936.23kb] [文件加载：59]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
---------------------------------------------------------------

[2020-03-11T15:03:36+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.256799s] [吞吐率：3.89req/s] [内存消耗：4,398.81kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:03:36+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.221866s] [吞吐率：4.51req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:03:39+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.673790s] [吞吐率：1.48req/s] [内存消耗：6,796.18kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.139355s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.092816s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.091694s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.091898s ]
---------------------------------------------------------------

[2020-03-11T15:05:50+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.236669s] [吞吐率：4.23req/s] [内存消耗：4,653.62kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:05:50+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.209455s] [吞吐率：4.77req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:31:33+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.237048s] [吞吐率：4.22req/s] [内存消耗：4,653.82kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:31:33+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.219198s] [吞吐率：4.56req/s] [内存消耗：4,271.33kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:31:38+08:00] ::1 GET localhost/tumor/public/index.php/admin/immuno_other
[运行时间：0.727721s] [吞吐率：1.37req/s] [内存消耗：6,527.53kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/immuno_other',
  'route' => '@admin/immother/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\immother\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.164078s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_immuno_other` [ RunTime:0.108320s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) [ RunTime:0.100790s ]
[ sql ] [ SQL ] SELECT * FROM `tp_immuno_other` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `biomarker` LIKE '%%'  OR `gene` LIKE '%%'  OR `variant_type` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.100633s ]
---------------------------------------------------------------

[2020-03-11T15:56:41+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.228761s] [吞吐率：4.37req/s] [内存消耗：4,402.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:56:41+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.229746s] [吞吐率：4.35req/s] [内存消耗：4,275.17kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:56:44+08:00] ::1 GET localhost/tumor/public/index.php/admin/chemotherapy
[运行时间：0.710684s] [吞吐率：1.41req/s] [内存消耗：6,794.81kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/chemotherapy',
  'route' => '@admin/chemo/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\chemo\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.143384s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_chemotherapy` [ RunTime:0.095033s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_chemotherapy` WHERE  (  `chemotherapy` LIKE '%%' OR `rs_site` LIKE '%%' ) [ RunTime:0.096094s ]
[ sql ] [ SQL ] SELECT * FROM `tp_chemotherapy` WHERE  (  `chemotherapy` LIKE '%%' OR `rs_site` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.094180s ]
---------------------------------------------------------------

[2020-03-11T15:57:18+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.241173s] [吞吐率：4.15req/s] [内存消耗：4,657.39kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:57:19+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.229833s] [吞吐率：4.35req/s] [内存消耗：4,275.17kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T15:57:21+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.693843s] [吞吐率：1.44req/s] [内存消耗：6,734.07kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.141549s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.098695s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.096741s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.095031s ]
---------------------------------------------------------------

[2020-03-11T16:02:33+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.219034s] [吞吐率：4.57req/s] [内存消耗：4,402.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:02:33+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.212843s] [吞吐率：4.70req/s] [内存消耗：4,275.17kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:02:35+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.698351s] [吞吐率：1.43req/s] [内存消耗：6,510.81kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.151718s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.100350s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.100203s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.102286s ]
---------------------------------------------------------------

[2020-03-11T16:28:02+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.225827s] [吞吐率：4.43req/s] [内存消耗：4,402.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:28:02+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.222349s] [吞吐率：4.50req/s] [内存消耗：4,275.17kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:28:04+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.718929s] [吞吐率：1.39req/s] [内存消耗：6,513.87kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.164710s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.104614s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.095492s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.096924s ]
---------------------------------------------------------------

[2020-03-11T16:28:08+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial/1/edit
[运行时间：0.586235s] [吞吐率：1.71req/s] [内存消耗：6,488.29kb] [文件加载：84]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>/edit',
  'route' => '@admin/clinical/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.138590s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.092479s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.092133s ]
---------------------------------------------------------------

[2020-03-11T16:29:56+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.226535s] [吞吐率：4.41req/s] [内存消耗：4,402.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:29:56+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.229949s] [吞吐率：4.35req/s] [内存消耗：4,275.17kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:29:58+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.682260s] [吞吐率：1.47req/s] [内存消耗：6,513.66kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.141830s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.095198s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.095969s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.096993s ]
---------------------------------------------------------------

[2020-03-11T16:29:59+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial/1/edit
[运行时间：0.619003s] [吞吐率：1.62req/s] [内存消耗：6,488.77kb] [文件加载：84]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>/edit',
  'route' => '@admin/clinical/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.147024s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.098457s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.098762s ]
---------------------------------------------------------------

[2020-03-11T16:30:14+08:00] ::1 PUT localhost/tumor/public/index.php/admin/clinicaltrial/1
[运行时间：0.178566s] [吞吐率：5.60req/s] [内存消耗：4,090.91kb] [文件加载：69]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>',
  'route' => '@admin/clinical/update',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '442',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial/1/edit',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'variant_type' => '靶向aaa',
  'gene' => 'AKT1',
  'chgvs' => 'NA',
  'phgvs' => 'E17K',
  'cancer_type' => '乳腺癌',
  'cancer_subtype' => 'NA',
  'clin_drug' => 'AZD5363（Capivasertib）',
  'clinicaltrial_id' => 'NCT03182634',
  'clinical_detail' => 'The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)',
  'clinical_site' => '英国',
  'state' => '招募中',
  'source' => 'NA',
  'note' => 'NA',
  'id' => '1',
)
---------------------------------------------------------------

[2020-03-11T16:30:16+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.694855s] [吞吐率：1.44req/s] [内存消耗：6,513.73kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.141173s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.094623s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.093918s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.095657s ]
---------------------------------------------------------------

[2020-03-11T16:35:36+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.222975s] [吞吐率：4.48req/s] [内存消耗：4,402.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:35:36+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.237588s] [吞吐率：4.21req/s] [内存消耗：4,275.17kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:35:38+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.679361s] [吞吐率：1.47req/s] [内存消耗：6,518.82kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.141454s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.092963s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.091520s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.094281s ]
---------------------------------------------------------------

[2020-03-11T16:35:40+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial/1/edit
[运行时间：0.639913s] [吞吐率：1.56req/s] [内存消耗：6,494.27kb] [文件加载：84]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>/edit',
  'route' => '@admin/clinical/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.161846s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.106750s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.107328s ]
---------------------------------------------------------------

[2020-03-11T16:35:44+08:00] ::1 PUT localhost/tumor/public/index.php/admin/clinicaltrial/1
[运行时间：0.550489s] [吞吐率：1.82req/s] [内存消耗：6,065.82kb] [文件加载：78]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>',
  'route' => '@admin/clinical/update',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '445',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial/1/edit',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'variant_type' => '靶向aaaaaa',
  'gene' => 'AKT1',
  'chgvs' => 'NA',
  'phgvs' => 'E17K',
  'cancer_type' => '乳腺癌',
  'cancer_subtype' => 'NA',
  'clin_drug' => 'AZD5363（Capivasertib）',
  'clinicaltrial_id' => 'NCT03182634',
  'clinical_detail' => 'The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)',
  'clinical_site' => '英国',
  'state' => '招募中',
  'source' => 'NA',
  'note' => 'NA',
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.143058s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.097370s ]
[ sql ] [ SQL ] UPDATE `tp_clinicaltrial`  SET `variant_type` = '靶向aaaaaa' , `gene` = 'AKT1' , `chgvs` = 'NA' , `phgvs` = 'E17K' , `cancer_type` = '乳腺癌' , `cancer_subtype` = 'NA' , `clin_drug` = 'AZD5363（Capivasertib）' , `clinicaltrial_id` = 'NCT03182634' , `clinical_detail` = 'The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)' , `clinical_site` = '英国' , `state` = '招募中' , `source` = 'NA' , `note` = 'NA'  WHERE  `id` = 1 [ RunTime:0.106775s ]
---------------------------------------------------------------

[2020-03-11T16:35:46+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.694287s] [吞吐率：1.44req/s] [内存消耗：6,518.83kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.139831s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.092202s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.094488s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.094594s ]
---------------------------------------------------------------

[2020-03-11T16:35:52+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial/1/edit
[运行时间：0.598887s] [吞吐率：1.67req/s] [内存消耗：6,224.19kb] [文件加载：82]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>/edit',
  'route' => '@admin/clinical/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.141555s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.095139s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.094735s ]
---------------------------------------------------------------

[2020-03-11T16:35:58+08:00] ::1 PUT localhost/tumor/public/index.php/admin/clinicaltrial/1
[运行时间：0.551262s] [吞吐率：1.81req/s] [内存消耗：6,065.55kb] [文件加载：78]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>',
  'route' => '@admin/clinical/update',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '439',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial/1/edit',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'variant_type' => '靶向',
  'gene' => 'AKT1',
  'chgvs' => 'NA',
  'phgvs' => 'E17K',
  'cancer_type' => '乳腺癌',
  'cancer_subtype' => 'NA',
  'clin_drug' => 'AZD5363（Capivasertib）',
  'clinicaltrial_id' => 'NCT03182634',
  'clinical_detail' => 'The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)',
  'clinical_site' => '英国',
  'state' => '招募中',
  'source' => 'NA',
  'note' => 'NA',
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.143120s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.095535s ]
[ sql ] [ SQL ] UPDATE `tp_clinicaltrial`  SET `variant_type` = '靶向' , `gene` = 'AKT1' , `chgvs` = 'NA' , `phgvs` = 'E17K' , `cancer_type` = '乳腺癌' , `cancer_subtype` = 'NA' , `clin_drug` = 'AZD5363（Capivasertib）' , `clinicaltrial_id` = 'NCT03182634' , `clinical_detail` = 'The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)' , `clinical_site` = '英国' , `state` = '招募中' , `source` = 'NA' , `note` = 'NA'  WHERE  `id` = 1 [ RunTime:0.099320s ]
---------------------------------------------------------------

[2020-03-11T16:36:00+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.714000s] [吞吐率：1.40req/s] [内存消耗：6,518.80kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.137268s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.090873s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.092590s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.092967s ]
---------------------------------------------------------------

[2020-03-11T16:41:49+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.229204s] [吞吐率：4.36req/s] [内存消耗：4,402.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:41:49+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.218976s] [吞吐率：4.57req/s] [内存消耗：4,275.17kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:41:51+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.730912s] [吞吐率：1.37req/s] [内存消耗：6,541.40kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.158831s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.105811s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.105691s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.107834s ]
---------------------------------------------------------------

[2020-03-11T16:41:58+08:00] ::1 DELETE localhost/tumor/public/index.php/admin/clinicaltrial/1
[运行时间：0.517578s] [吞吐率：1.93req/s] [内存消耗：6,130.02kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>',
  'route' => '@admin/clinical/delete',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'accept' => '*/*',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.137771s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.091355s ]
[ sql ] [ SQL ] DELETE FROM `tp_clinicaltrial` WHERE  `id` = 1 [ RunTime:0.109779s ]
---------------------------------------------------------------

[2020-03-11T16:42:06+08:00] ::1 POST localhost/tumor/public/index.php/admin/clinicaltrial/delAll
[运行时间：0.108006s] [吞吐率：9.26req/s] [内存消耗：2,799.43kb] [文件加载：55]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
---------------------------------------------------------------

[2020-03-11T16:43:06+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.229128s] [吞吐率：4.36req/s] [内存消耗：4,414.26kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:43:07+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.223763s] [吞吐率：4.47req/s] [内存消耗：4,286.56kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:43:09+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.675557s] [吞吐率：1.48req/s] [内存消耗：6,552.87kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.138864s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.093630s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.095434s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.095563s ]
---------------------------------------------------------------

[2020-03-11T16:43:15+08:00] ::1 POST localhost/tumor/public/index.php/admin/clinicaltrial/delAll
[运行时间：0.515195s] [吞吐率：1.94req/s] [内存消耗：6,121.85kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/delAll',
  'route' => '@admin/clinical/delAll',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '33',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'ids' => '2,3,4,5,6,7,8,9',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.142386s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.094981s ]
[ sql ] [ SQL ] DELETE FROM `tp_clinicaltrial` WHERE  `id` IN (2,3,4,5,6,7,8,9) [ RunTime:0.096694s ]
---------------------------------------------------------------

[2020-03-11T16:43:18+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.649626s] [吞吐率：1.54req/s] [内存消耗：6,553.37kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.130515s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.088005s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.088278s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.088553s ]
---------------------------------------------------------------

[2020-03-11T16:44:57+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.237956s] [吞吐率：4.20req/s] [内存消耗：4,414.26kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:44:57+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.248694s] [吞吐率：4.02req/s] [内存消耗：4,286.56kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T16:44:58+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.660148s] [吞吐率：1.51req/s] [内存消耗：6,509.30kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.137295s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.091667s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.092522s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.092807s ]
---------------------------------------------------------------

[2020-03-11T16:45:11+08:00] ::1 POST localhost/tumor/public/index.php/admin/clinicaltrial/upload
[运行时间：7.032161s] [吞吐率：0.14req/s] [内存消耗：28,000.03kb] [文件加载：127]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/upload',
  'route' => '@admin/clinical/upload',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '214230',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'multipart/form-data; boundary=----WebKitFormBoundaryeHVL90r73NpkX0Kd',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.134129s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.089579s ]
[ sql ] [ SQL ] INSERT INTO `tp_clinicaltrial` (`variant_type` , `gene` , `chgvs` , `phgvs` , `cancer_type` , `cancer_subtype` , `clin_drug` , `clinicaltrial_id` , `clinical_detail` , `clinical_site` , `state` , `source` , `note`) VALUES ( '靶向','AKT1','NA','E17K','乳腺癌','NA','AZD5363（Capivasertib）','NCT03182634','The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)','英国','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','乳腺癌','NA','AZD5363（Capivasertib）','NCT03310541','AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations','美国','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','乳腺癌','NA','AZD5363（Capivasertib）','NCT02299999','SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer (SAFIR02_Breast)','法国','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','乳腺癌','NA','AZD5363（Capivasertib）','NCT01226316','Safety, Tolerability # Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules','美国、加拿大、丹麦、法国、意大利、日本、新加坡、西班牙','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','乳腺癌','NA','AZD5363（Capivasertib）','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','乳腺癌','NA','ipatasertib','NCT03337724','A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer (IPATunity130)','美国、澳大利亚、日本、新加坡、中国台湾、中国等多个国家和地区','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','子宫内膜癌','NA','AZD5363（Capivasertib）','NCT01226316','Safety, Tolerability # Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules','美国、加拿大、丹麦、法国、意大利、日本、新加坡、西班牙','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','癌种未区分','NA','GSK2636771','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','癌种未区分','NA','AZD5363（Capivasertib）','NCT03182634','The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)','英国','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','癌种未区分','NA','AZD5363（Capivasertib）','NCT03310541','AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations','美国','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','癌种未区分','NA','AZD5363（Capivasertib）','NCT02299999','SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer (SAFIR02_Breast)','法国','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','癌种未区分','NA','AZD5363（Capivasertib）','NCT01226316','Safety, Tolerability # Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules','美国、加拿大、丹麦、法国、意大利、日本、新加坡、西班牙','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','癌种未区分','NA','AZD5363（Capivasertib）','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','AKT1','NA','E17K','癌种未区分','NA','ipatasertib','NCT03337724','A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer (IPATunity130)','美国、澳大利亚、日本、新加坡、中国台湾、中国等多个国家和地区','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','乳腺癌','NA','克唑替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','乳腺癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','美国、澳大利亚、法国、德国、中国香港、意大利、韩国、荷兰、波兰、新加坡、西班牙、中国台湾、英国','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','乳腺癌','NA','Entrectinib','NCT02650401','Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','结直肠癌','NA','克唑替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','结直肠癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','美国、澳大利亚、法国、德国、中国香港、意大利、韩国、荷兰、波兰、新加坡、西班牙、中国台湾、英国','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','结直肠癌','NA','Entrectinib','NCT02650401','Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','肉瘤','上皮样#炎性肌纤维母细胞','Entrectinib','NCT02650401','Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1174L','神经母细胞瘤','NA','Lorlatinib','NCT03107988','Study of Lorlatinib (PF-06463922)','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1174L','神经母细胞瘤','NA','赛瑞替尼、Ribociclib','NCT02780128','Next Generation Personalized Neuroblastoma Therapy (NEPENTHE)','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1174L','神经母细胞瘤','NA','Ensartinib','NCT03213652','Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1174L','神经母细胞瘤','NA','Ensartinib','NCT03155620','Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1245C','神经母细胞瘤','NA','Lorlatinib','NCT03107988','Study of Lorlatinib (PF-06463922)','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1245C','神经母细胞瘤','NA','赛瑞替尼、Ribociclib','NCT02780128','Next Generation Personalized Neuroblastoma Therapy (NEPENTHE)','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1245C','神经母细胞瘤','NA','Ensartinib','NCT03213652','Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','F1245C','神经母细胞瘤','NA','Ensartinib','NCT03155620','Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','R1275Q','神经母细胞瘤','NA','Lorlatinib','NCT03107988','Study of Lorlatinib (PF-06463922)','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','R1275Q','神经母细胞瘤','NA','赛瑞替尼、Ribociclib','NCT02780128','Next Generation Personalized Neuroblastoma Therapy (NEPENTHE)','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','R1275Q','神经母细胞瘤','NA','Ensartinib','NCT03213652','Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','R1275Q','神经母细胞瘤','NA','Ensartinib','NCT03155620','Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','甲状腺癌','NA','Entrectinib','NCT02650401','Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions','美国','招募中','NA','NA' ) , ( '靶向','ALK','NA','重排','甲状腺癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','美国、澳大利亚、法国、德国、中国香港、意大利、韩国、荷兰、波兰、新加坡、西班牙、中国台湾、英国','招募中','NA','NA' ) , ( '靶向','ATM','NA','V2288fs*1','前列腺癌','NA','奥拉帕利','NCT03012321','Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate CancerWith DNA Repair Defects','美国','招募中','NA','NA' ) , ( '靶向','ATM','NA','V2288fs*1','前列腺癌','NA','奥拉帕利','NCT03570476','Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','ATM','NA','V2288fs*1','前列腺癌','NA','Rucaparib','NCT02952534','A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON2)','美国、澳大利亚、比利时、加拿大、丹麦、法国、德国、爱尔兰、以色列、意大利、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ATM','NA','V2288fs*1','前列腺癌','NA','Rucaparib','NCT03442556','Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency','美国','招募中','NA','NA' ) , ( '靶向','ATM','NA','V2288fs*1','前列腺癌','NA','Talazoparib','NCT03330405','Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors','美国、澳大利亚、加拿大、丹麦、匈牙利、俄罗斯联邦','招募中','NA','NA' ) , ( '靶向','ATM','NA','N2875H','前列腺癌','NA','奥拉帕利','NCT03012321','Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate CancerWith DNA Repair Defects','美国','招募中','NA','NA' ) , ( '靶向','ATM','NA','N2875H','前列腺癌','NA','奥拉帕利','NCT03570476','Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','ATM','NA','N2875H','前列腺癌','NA','Rucaparib','NCT02952534','A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON2)','美国、澳大利亚、比利时、加拿大、丹麦、法国、德国、爱尔兰、以色列、意大利、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ATM','NA','N2875H','前列腺癌','NA','Rucaparib','NCT03442556','Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency','美国','招募中','NA','NA' ) , ( '靶向','ATM','NA','N2875H','前列腺癌','NA','Talazoparib','NCT03330405','Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors','美国、澳大利亚、加拿大、丹麦、匈牙利、俄罗斯联邦','招募中','NA','NA' ) , ( '靶向','BRAF','NA','扩增','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRAF','NA','D594G','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRAF','NA','G469A','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRAF','NA','V600D','黑色素瘤','NA','Atezolizumab','NCT02902029','Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma (ImmunoCobiVem)','法国','招募中','NA','NA' ) , ( '靶向','BRAF','NA','V600E','黑色素瘤','NA','Dabrafenib/Trametinib','NCT03088176','Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma','美国','招募中','NA','NA' ) , ( '靶向','BRAF','NA','V600E','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1V','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','M1I','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','乳腺癌','NA','Niraparib','NCT02826512','A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients','荷兰','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','乳腺癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','乳腺癌','NA','BGB-290（Pamiparib）','NCT03575065','Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China','黑龙江哈尔滨肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','乳腺癌','NA','BGB-290（Pamiparib）','CTR20171623','一项评估BGB-290在携带BRCA突变的中国转移性HER2阴性乳腺癌患者的有效性和安全性的开放、多中心、2期研究','中国医学科学院肿瘤医院、福建医科大学附属协和医院、河南省肿瘤医院、江苏省人民医院、吉林大学第一医院、四川大学华西医院、武汉大学中南医院、吉林省肿瘤医院、云南省肿瘤医院、辽宁省肿瘤医院、中山大学肿瘤防治中心、山东省肿瘤医院等','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','乳腺癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','乳腺癌','NA','Veliparib','NCT02595905','Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','乳腺癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C61G','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','C64Y','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71G','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R71K','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1495M','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','E1559K','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','D1692N','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','R1443*','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','Q1467*','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','IMP4297','CTR20170271','评价IMP4297胶囊在标准治疗无效的晚期实体瘤患者中的安全性、耐受性及药物代谢动力学特征的I期临床试验','中国医学科学院肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','Fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA1','NA','W1815*','卵巢癌','NA','氟唑帕利','CTR20180156','氟唑帕利治疗BRCA1/2突变的复发性卵巢癌的单臂、多中心Ⅰb期临床研究','中国医学科学院肿瘤医院、北京大学第三医院、中国人民解放军海军总医院、天津市肿瘤医院、天津医科大学总医、中南大学湘雅医院、湖南省肿瘤医院、 华中科技大学同济医学院附属协和医院、浙江大学医学院附属邵逸夫医院、重庆市肿瘤医院、南京鼓楼医院、山东大学齐鲁医院、复旦大学附属肿瘤医院、中山大学附属第一医院、中山大学附属肿瘤医院、哈尔滨医科大学附属肿瘤医院、 复旦大学附属妇产科医院（上海红房子）、四川大学华西第二医院、南昌大学第二附属医院、河南省肿瘤医院、浙江省肿瘤医院、中国人民解放军总医院、江苏省肿瘤医院、安徽医科大','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1I','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1I','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1I','卵巢癌','NA','fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1I','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1I','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1R','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1R','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1R','卵巢癌','NA','fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1R','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','M1R','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V159M','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336H','乳腺癌','NA','奥拉帕利','NCT03344965','Olaparib In Metastatic Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336H','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336H','卵巢癌','NA','fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336H','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336H','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336P','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336P','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336P','卵巢癌','NA','fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336P','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','R2336P','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V159M','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V159M','卵巢癌','NA','Talazoparib','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V159M','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V159M','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211I','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211I','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211I','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211I','卵巢癌','NA','Adavosertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211L','乳腺癌','NA','Niraparib','NCT03329937','Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211L','卵巢癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211L','卵巢癌','NA','Talazoparib','NCT01989546','Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations','美国','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211L','卵巢癌','NA','fluzoparib （SHR-3162）','NCT03509636','A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','BRCA2','NA','V211L','卵巢癌','NA','LY2606368（Prexasertib）','NCT02203513','A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer','美国','招募中','NA','NA' ) , ( '靶向','CDKN2A','NA','缺失','胰腺癌','NA','NA','NCT03524677','Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis','罗马','招募中','NA','NA' ) , ( '靶向','CDKN2A','NA','缺失','神经母细胞瘤','NA','西妥昔单抗或EGFR抗体','NCT03356223','Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and','法国','招募中','NA','NA' ) , ( '靶向','EGFR','NA','L858R','神经母细胞瘤','NA','阿法替尼','NCT02423525','Safety Study of Afatinib for Brain Cancer','美国','招募中','NA','NA' ) , ( '靶向','EGFR','NA','R108K','神经母细胞瘤','NA','阿法替尼','NCT02423525','Safety Study of Afatinib for Brain Cancer','美国','招募中','NA','NA' ) , ( '靶向','EGFR','NA','T263P','神经母细胞瘤','NA','阿法替尼','NCT02423525','Safety Study of Afatinib for Brain Cancer','美国','招募中','NA','NA' ) , ( '靶向','EGFR','NA','P753S','皮肤癌','鳞状','西妥昔单抗','NCT03082534','Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head # Neck Squamous Cell Carcinoma','美国','招募中','NA','NA' ) , ( '靶向','EGFR','NA','P753S','皮肤癌','鳞状','西妥昔单抗','NCT02324608','Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer','美国','招募中','NA','NA' ) , ( '靶向','EGFR','NA','P753S','皮肤癌','鳞状','西妥昔单抗','NCT03524326','Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胆道肿瘤','NA','帕妥珠单抗+曲妥珠单抗','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胆道肿瘤','NA','帕妥珠单抗+曲妥珠单抗','NCT02693535','TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (TAPUR)','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胆道肿瘤','NA','TAS0728','NCT03410927','A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities','美国、法国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','膀胱癌','NA','帕妥珠单抗+曲妥珠单抗','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','膀胱癌','NA','帕妥珠单抗+曲妥珠单抗','NCT02693535','TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (TAPUR)','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','膀胱癌','NA','A166','NCT03602079','Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','乳腺癌','NA','A166','NCT03602079','Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','乳腺癌','NA','吡咯替尼','CTR20180941','马来酸吡咯替尼片术前三药联合治疗乳腺癌的临床研究','复旦大学附属肿瘤医院、中国人民解放军第三〇七医院、北京大学人民医院、浙江大学医学院附属第一医院、青岛大学附属医院、青岛大学附属医院、河北医科大学第四医院、中山大学附属肿瘤医院、江苏省人民医院、河南省肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','乳腺癌','NA','Hemay022片','CTR20170726','Hemay022联合依西美坦治疗乳腺癌的耐受性及初步有效性研究','北京肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','乳腺癌','NA','甲苯磺酸赛拉替尼片','CTR20161036','赛拉替尼片治疗HER2阳性晚期乳腺癌患者II期临床','中国医学科学院肿瘤医院、哈尔滨医科大学附属肿瘤医院、吉林大学第一医院、辽宁省肿瘤医院、中国人民解放军总医院、北京肿瘤医院、河北医科大学第四医院、山东大学齐鲁医院、西安交通大学第一附属医院、蚌埠医学院第一附属医院、江苏省肿瘤医院、浙江省肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','乳腺癌','NA','甲苯磺酸艾力替尼片','CTR20150568','甲苯磺酸艾力替尼片的Ib期临床耐受性及药代动力学试验','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','乳腺癌','NA','Hemay022片','CTR20150326','Hemay022治疗晚期HER2阳性乳腺癌的耐受性和药代动力学研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769H','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','D769Y','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','755-759del','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','G309A','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755W','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','Poziotinib','NCT03066206','Poziotinib in EGFR Exon 20 Mutant Advanced Non-Small Cell Lung Cancer (NSCLC) and HER2 Exon 20 Mutant NSCLC','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','吡咯替尼','NCT02834936','A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation','上海市肺科医院、HR-BLTN-II-NSCLC研究中心（北京、长沙、广州、杭州、哈尔滨、南京、上海、苏州、武汉、郑州）','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','AP32788（TAK-788）','NCT02716116','A Trial of TAK-788 (AP32788) in Non-small Cell Lung Cancer (NSCLC)','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','阿法替尼','NCT02183883','Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity (DARWIN1)','英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','Trastuzumab deruxtecan (DS-8201a)','NCT03505710','DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer','美国、日本','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','Poziotinib','NCT03318939','Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','P780ins','肺癌','NA','甲苯磺酸艾力替尼片','CTR20150258','甲苯黄酸艾力替尼片治疗非小细胞肺癌的Ⅱ期临床试验','广东省人民医院临床试验基地肿瘤中心肺科','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R678Q','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','R896C','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','Gedatolisib','NCT02626507','Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','阿帕替尼','NCT03535961','Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','TAK-228（Sapanisertib）','NCT02619669','Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','Neratinib','NCT01670877','Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer','美国、加拿大','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','AZD9833','NCT03616587','Study of AZD9833 Alone or in Combination With Palbociclib in Women With Advanced Breast Cancer','美国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','D-0502','NCT03471663','A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','G1T38','NCT02983071','G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer','保加利亚、乔治亚、英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','G1T48','NCT03455270','G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer','美国、比利时、荷兰','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','SHR9549片','CTR20181130','SHR9549片在ER阳性、HER2阴性晚期乳腺癌患者的I期临床研究','中国人民解放军第三〇七医院、江苏省人民医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','乳腺癌','NA','LXI-15029 胶囊','CTR20170273','针对晚期恶性实体肿瘤的LXI-15029Ⅰ期研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','结直肠癌','NA','Ado-trastuzumab emtansine','NCT03418558','Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib. (RESCUE)','意大利','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','结直肠癌','NA','Tucatinib+曲妥珠单抗','NCT03043313','Tucatinib (ONT-380) and Trastuzumab in Treating Patients With HER2+ Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','结直肠癌','NA','帕妥珠单抗+曲妥珠单抗','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L755S','结直肠癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','L866M','结直肠癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','S310F','结直肠癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','S310Y','结直肠癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V777L','结直肠癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V842I','结直肠癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','子宫内膜癌','NA','帕妥珠单抗','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','食管癌','NA','ibrutinib','NCT02884453','Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma (iMYC)','英国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','食管癌','NA','吡咯替尼','CTR20150178','马来酸吡咯替尼I期临床耐受性及药代动力学试验','北京大学肿瘤医院、中山大学附属肿瘤医院、中国医学科学院肿瘤医院、中国人民解放军总医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胃癌','NA','A166','NCT03602079','Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胃癌','NA','注射用重组人源化抗HER2单抗-MMAE偶联剂','CTR20180844','RC48-ADC治疗HER2过表达局部晚期或转移性胃癌II期临床研究','北京肿瘤医院、天津市肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胃癌','NA','注射用重组人源化抗HER2双特异性抗体','CTR20180690','KN026治疗HER2阳性晚期恶性乳腺癌、胃癌I期临床研究','复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胃癌','NA','吡咯替尼','CTR20150178','马来酸吡咯替尼I期临床耐受性及药代动力学试验','北京大学肿瘤医院、中山大学附属肿瘤医院、中国医学科学院肿瘤医院、中国人民解放军总医院','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','头颈部肿瘤','NA','帕妥珠单抗+曲妥珠单抗','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','V773A','头颈部肿瘤','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','H878Y','肝癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','肺癌','NA','帕妥珠单抗+曲妥珠单抗','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','肺癌','NA','A166','NCT03602079','Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','肺癌','NA','甲苯磺酸艾力替尼片','CTR20150258','甲苯黄酸艾力替尼片治疗非小细胞肺癌的Ⅱ期临床试验','广东省人民医院临床试验基地肿瘤中心肺科','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','N857S','卵巢癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胰腺癌','NA','帕妥珠单抗+曲妥珠单抗','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','扩增','胰腺癌','NA','A166','NCT03602079','Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene','美国','招募中','NA','NA' ) , ( '靶向','ERBB2','NA','T862A','胃癌','NA','阿法替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-MGEA5','胆道肿瘤','NA','BGJ398','NCT02150967','A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma','QED Therapeutics, Inc.','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-MGEA5','胆道肿瘤','NA','AZD4547、Erdafitinib、Debio1347','NCT02465060','rgeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-TACC3','胆道肿瘤','NA','BGJ398','NCT02150967','A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma','QED Therapeutics, Inc.','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-TACC3','胆道肿瘤','NA','AZD4547、Erdafitinib、Debio1347','NCT02699606','A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Chol','北京大学肿瘤医院','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-TACC3','胆道肿瘤','NA','AZD4547、Erdafitinib、Debio1347','NCT03547037','A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Soli','国立癌症中心医院（日本）','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-BICC1','胆道肿瘤','NA','BGJ398','NCT02150967','A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma','QED Therapeutics, Inc.','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-BICC1','胆道肿瘤','NA','AZD4547、Erdafitinib、Debio1347','NCT01948297','Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations','台北医科大学医院（台湾）','招募中','NA','NA' ) , ( '靶向','FGFR2','NA','FGFR2-AHCYL1','子宫内膜癌','NA','JNJ-42756493（Erdafitinib）','NCT02952573','Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement','多伦多','招募中','NA','NA' ) , ( '靶向','FGFR3','NA','S249C','肺癌','非小细胞#非鳞','BGJ398','NCT02706691','BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer','美国','招募中','NA','NA' ) , ( '靶向','FGFR3','NA','FGFR3-TACC3','癌种未区分','NA','JNJ-42756493（Erdafitinib）','NCT02699606','A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Chol','北京大学肿瘤医院','招募中','NA','NA' ) , ( '靶向','FGFR3','NA','FGFR3-TACC3','癌种未区分','NA','JNJ-42756493（Erdafitinib）','NCT03210714','Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)','美国','招募中','NA','NA' ) , ( '靶向','FGFR3','NA','FGFR3-TACC3','癌种未区分','NA','JNJ-42756493（Erdafitinib）','NCT03155620','Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)','美国','招募中','NA','NA' ) , ( '靶向','HRAS','NA','G13D','结直肠癌','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','IDH1','NA','mutation','神经母细胞瘤','NA','奥拉帕利','NCT03212274','Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations','美国','招募中','NA','NA' ) , ( '靶向','IDH2','NA','mutation','神经母细胞瘤','NA','奥拉帕利','NCT03212274','Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations','美国','招募中','NA','NA' ) , ( '靶向','KIT','NA','C809G','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','C809G','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','D816H','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','D816H','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','D820A','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','D820A','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','D820G','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','D820G','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','N822K','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','N822K','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','T670I','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','T670I','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','V559D','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','V559D','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','V654A','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','V654A','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','Y823D','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','台湾省立卫生研究院','招募中','NA','NA' ) , ( '靶向','KIT','NA','Y823D','胃肠道间质瘤','NA','Avapritinib','NCT02508532','(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors','美国、比利时、法国、德国、意大利、韩国、荷兰、波兰、西班牙、英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','D820Y','黑色素瘤','NA','PLX3397（Pexidartinib）','NCT02071940','PLX3397 KIT in Acral aNd mucOsal Melanoma (PIANO)','英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','D820Y','黑色素瘤','NA','瑞戈非尼','NCT02501551','Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy','韩国','招募中','NA','NA' ) , ( '靶向','KIT','NA','D816H','黑色素瘤','NA','PLX3397（Pexidartinib）','NCT02071940','PLX3397 KIT in Acral aNd mucOsal Melanoma (PIANO)','英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','D816H','黑色素瘤','NA','瑞戈非尼','NCT02501551','Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy','韩国','招募中','NA','NA' ) , ( '靶向','KIT','NA','K642E','黑色素瘤','NA','PLX3397（Pexidartinib）','NCT02071940','PLX3397 KIT in Acral aNd mucOsal Melanoma (PIANO)','英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','K642E','黑色素瘤','NA','瑞戈非尼','NCT02501551','Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy','韩国','招募中','NA','NA' ) , ( '靶向','KIT','NA','L576P','黑色素瘤','NA','PLX3397（Pexidartinib）','NCT02071940','PLX3397 KIT in Acral aNd mucOsal Melanoma (PIANO)','英国','招募中','NA','NA' ) , ( '靶向','KIT','NA','L576P','黑色素瘤','NA','瑞戈非尼','NCT02501551','Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy','韩国','招募中','NA','NA' ) , ( '靶向','KIT','NA','扩增','黑色素瘤','NA','瑞戈非尼','NCT02501551','Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy','韩国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','A146P','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','A146T','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','A146V','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','A146V','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','A146V','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','扩增','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','EXON 2 MUTATION','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','EXON 2 MUTATION','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','EXON 2 MUTATION','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12','肺癌','NA','Binimetinib','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12A','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12A','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12A','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12C','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12C','结直肠癌','NA','MRTX849','NCT03785249','MRTX849 in Patients With Cancer Having a KRAS G12C Mutation','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12C','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12C','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12D','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12D','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12D','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12R','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12R','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12R','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12S','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12S','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12S','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12V','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12V','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G12V','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G13','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G13','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G13','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G13D','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G13D','肺癌','NA','Binimetinib+哌柏西利','NCT03170206','Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the MEK Inhibitor Binimetinib (MEK162) for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','G13D','肺癌','NA','瑞戈非尼','NCT03520842','Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','Q22*','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','Q61','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','KRAS','NA','Q61H','结直肠癌','NA','Binimetinib','NCT02613650','A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers','美国','招募中','NA','NA' ) , ( '靶向','MAP2K1','NA','C121S','黑色素瘤','NA','Trametinib','NCT02382549','A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib (Mel61)','美国','招募中','NA','NA' ) , ( '靶向','MAP2K1','NA','C121S','黑色素瘤','NA','Selumetinib (AZD6244)','NCT02768766','Intermittent Selumetinib for Uveal Melanoma','美国','招募中','NA','NA' ) , ( '靶向','MAP2K1','NA','P124S','黑色素瘤','NA','Trametinib','NCT02382549','A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib (Mel61)','美国','招募中','NA','NA' ) , ( '靶向','MAP2K1','NA','P124S','黑色素瘤','NA','Selumetinib (AZD6244)','NCT02768766','Intermittent Selumetinib for Uveal Melanoma','美国','招募中','NA','NA' ) , ( '靶向','MAP2K1','NA','Q56P','黑色素瘤','NA','Trametinib','NCT02382549','A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib (Mel61)','美国','招募中','NA','NA' ) , ( '靶向','MAP2K1','NA','Q56P','黑色素瘤','NA','Selumetinib (AZD6244)','NCT02768766','Intermittent Selumetinib for Uveal Melanoma','美国','招募中','NA','NA' ) , ( '靶向','MET','NA','扩增','结直肠癌','NA','克唑替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','MET','NA','扩增','胃癌','NA','克唑替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','MET','NA','扩增','神经母细胞瘤','NA','克唑替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','MET','NA','扩增','肾癌','NA','克唑替尼','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','E2014K','膀胱癌','NA','Rapamycin','NCT02753309','A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer','美国','招募中','NA','NA' ) , ( '靶向','mTOR','NA','E2014K','膀胱癌','NA','Rapamycin','NCT02009332','Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer','美国','招募中','NA','NA' ) , ( '靶向','mTOR','NA','E2419K','膀胱癌','NA','Sirolimus (Rapamycin)','NCT02753309','A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer','美国','招募中','NA','NA' ) , ( '靶向','mTOR','NA','E2419K','膀胱癌','NA','ABI-009（Rapamycin）','NCT02009332','Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer','美国','招募中','NA','NA' ) , ( '靶向','mTOR','NA','S2215Y','子宫内膜癌','NA','AZD2014（Vistusertib）','NCT02730923','Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) (VICTORIA)','法国','招募中','NA','NA' ) , ( '靶向','mTOR','NA','E1799K','肾癌','透明细胞','sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','E1799K','肾癌','透明细胞','依维莫司+RX-0201','NCT02089334','Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer','美国','招募中','NA','NA' ) , ( '靶向','mTOR','NA','L1460P','肾癌','NA','贝伐珠单抗+索拉非尼','NCT02330783','Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients','北京大学第一医院、北京肿瘤医院','招募中','NA','NA' ) , ( '靶向','mTOR','NA','L1460P','肾癌','NA','sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','L2209V','肾癌','NA','贝伐珠单抗+索拉非尼','NCT02330783','Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients','北京大学第一医院、北京肿瘤医院','招募中','NA','NA' ) , ( '靶向','mTOR','NA','L2209V','肾癌','NA','sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','L2427Q','肾癌','NA','贝伐珠单抗+索拉非尼','NCT02330783','Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients','北京大学第一医院、北京肿瘤医院','招募中','NA','NA' ) , ( '靶向','mTOR','NA','L2427Q','肾癌','NA','sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','Q2223K','肾癌','NA','贝伐珠单抗+索拉非尼','NCT02330783','Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients','北京大学第一医院、北京肿瘤医院','招募中','NA','NA' ) , ( '靶向','mTOR','NA','Q2223K','肾癌','NA','sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','H1968Y','黑色素瘤','NA','sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','P2213S','黑色素瘤','NA','sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','mTOR','NA','F2108L','甲状腺癌','NA','Sapanisertib','NCT02244463','A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer','美国','招募中','NA','NA' ) , ( '靶向','mTOR','NA','F2108L','甲状腺癌','NA','Sapanisertib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G12D','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G12D','结直肠癌','NA','TP-0903','NCT02729298','First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G12D','结直肠癌','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G12D','结直肠癌','NA','Binimetinib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q179*','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q179*','结直肠癌','NA','TP-0903','NCT02729298','First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q179*','结直肠癌','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','结直肠癌','NA','TP-0903','NCT02729298','First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','结直肠癌','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','结直肠癌','NA','Binimetinib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','结直肠癌','NA','AZD1775','NCT02906059','Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','结直肠癌','NA','TP-0903','NCT02729298','First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','结直肠癌','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','结直肠癌','NA','Binimetinib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G13D','黑色素瘤','NA','LXH254、LTT462、Trametinib、Ribociclib','NCT02974725','A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma','美国、澳大利亚、比利时、法国、德国、意大利、西班牙','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G13D','黑色素瘤','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G13D','黑色素瘤','NA','Binimetinib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','G13D','黑色素瘤','NA','HL-085胶囊','CTR20171061','HL-085治疗NRAS突变晚期黑色素瘤的I/II期临床研究','北京肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61L','黑色素瘤','NA','LXH254、LTT462、Trametinib、Ribociclib','NCT02974725','A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma','美国、澳大利亚、比利时、法国、德国、意大利、西班牙','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61L','黑色素瘤','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61L','黑色素瘤','NA','Binimetinib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61L','黑色素瘤','NA','HL-085胶囊','CTR20171061','HL-085治疗NRAS突变晚期黑色素瘤的I/II期临床研究','北京肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','黑色素瘤','NA','LXH254、LTT462、Trametinib、Ribociclib','NCT02974725','A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma','美国、澳大利亚、比利时、法国、德国、意大利、西班牙','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','黑色素瘤','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','黑色素瘤','NA','Binimetinib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61R','黑色素瘤','NA','HL-085胶囊','CTR20171061','HL-085治疗NRAS突变晚期黑色素瘤的I/II期临床研究','北京肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','黑色素瘤','NA','LXH254、LTT462、Trametinib、Ribociclib','NCT02974725','A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma','美国、澳大利亚、比利时、法国、德国、意大利、西班牙','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','黑色素瘤','NA','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','黑色素瘤','NA','Binimetinib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','黑色素瘤','NA','HL-085胶囊','CTR20171061','HL-085治疗NRAS突变晚期黑色素瘤的I/II期临床研究','北京肿瘤医院、复旦大学附属肿瘤医院','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','神经母细胞瘤','NA','selumetinib','NCT03213691','Selumetinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','神经母细胞瘤','NA','ulixertinib','NCT03698994','Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','肺癌','非小细胞','PDR001','NCT03693326','PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities','韩国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','肺癌','非小细胞','LXH254、LTT462、Trametinib、Ribociclib','NCT02974725','A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma','美国、澳大利亚、比利时、法国、德国、意大利、西班牙','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','肺癌','非小细胞','ASN007 RD','NCT03415126','A Study of ASN007 in Patients With Advanced Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','NRAS','NA','Q61K','肺癌','非小细胞','Binimetinib、Talazoparib','NCT03637491','A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors','美国','招募中','NA','NA' ) , ( '靶向','PDGFRA','NA','D842V','胃肠道间质瘤','NA','Crenolanib','NCT02847429','Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST','美国、法国、德国、意大利、挪威、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','PDGFRA','NA','D842V','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','中国台湾','招募中','NA','NA' ) , ( '靶向','PDGFRA','NA','D842I','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','中国台湾','招募中','NA','NA' ) , ( '靶向','PDGFRA','NA','D842Y','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','中国台湾','招募中','NA','NA' ) , ( '靶向','PDGFRA','NA','I843del','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','中国台湾','招募中','NA','NA' ) , ( '靶向','PDGFRA','NA','V561A','胃肠道间质瘤','NA','AUY922','NCT01389583','A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients','中国台湾','招募中','NA','NA' ) , ( '靶向','PDGFRA','NA','扩增','肺癌','非小细胞','MGCD516（Sitravatinib）','NCT02219711','Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer','美国、韩国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E542K','乳腺癌','NA','Copanlisib','NCT02705859','Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study) (Panther)','爱尔兰','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E542K','乳腺癌','NA','Copanlisib','NCT03128619','Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer','美国','招募中','NA','HER2扩增' ) , ( '靶向','PIK3CA','NA','E542K','乳腺癌','NA','GDC-0077','NCT03006172','To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer','美国、加拿大、法国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E542K','乳腺癌','NA','Taselisib','NCT02390427','Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E545K','乳腺癌','HER2阳性','Copanlisib','NCT02705859','Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study) (Panther)','爱尔兰','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E545K','乳腺癌','HER2阳性','Copanlisib','NCT03128619','Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer','美国','招募中','NA','HER2扩增' ) , ( '靶向','PIK3CA','NA','E545K','乳腺癌','NA','GDC-0077','NCT03006172','To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer','美国、加拿大、法国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E545K','乳腺癌','HER2阳性','Taselisib','NCT02390427','Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','乳腺癌','HER2阳性','Copanlisib','NCT02705859','Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study) (Panther)','爱尔兰','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','乳腺癌','HER2阳性','Copanlisib','NCT03128619','Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer','美国','招募中','NA','HER2扩增' ) , ( '靶向','PIK3CA','NA','H1047R','乳腺癌','NA','GDC-0077','NCT03006172','To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer','美国、加拿大、法国、西班牙、英国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','乳腺癌','HER2阳性','Taselisib','NCT02390427','Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','头颈部肿瘤','鳞状','BYL719（Alpelisib）','NCT02537223','Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer','加拿大','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','头颈部肿瘤','鳞状','BYL719（Alpelisib）','NCT02145312','An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.','韩国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','头颈部肿瘤','鳞状','BYL719（Alpelisib）','NCT03292250','Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)','韩国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','头颈部肿瘤','鳞状','BYL719（Alpelisib）','NCT03138070','A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719','加拿大','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','扩增','头颈部肿瘤','鳞状','Taselisib','NCT02390427','Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E542K','甲状腺癌','NA','Temsirolimus','NCT01552434','Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E542K','甲状腺癌','NA','Temsirolimus','NCT03099356','Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','甲状腺癌','NA','Temsirolimus','NCT01552434','Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','H1047R','甲状腺癌','NA','Temsirolimus','NCT03099356','Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer','美国','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','E545K','黑色素瘤','NA','Taselisib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','PIK3CA','NA','D350G','黑色素瘤','NA','Taselisib','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','PTEN','NA','R233*','乳腺癌','NA','拉帕替尼','NCT03273595','Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer','山西西京医院','招募中','NA','NA' ) , ( '靶向','PTEN','NA','R233*','乳腺癌','NA','Talazoparib','NCT02286687','Study of the PARP Inhibitor BMN 673 in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in PTEN or PTEN Loss, a Homologous Recombination Defect, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA','美国','招募中','NA','NA' ) , ( '靶向','PTEN','NA','R233*','乳腺癌','NA','奥拉帕利','NCT02684318','Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors','西班牙','招募中','NA','NA' ) , ( '靶向','PTEN','NA','V317fs','黑色素瘤','NA','GSK2636771','NCT03131908','Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss','美国','招募中','NA','NA' ) , ( '靶向','PTEN','NA','V317fs','黑色素瘤','NA','Niraparib','NCT03207347','A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)','美国','招募中','NA','NA' ) , ( '靶向','PTEN','NA','V317fs','黑色素瘤','NA','GSK2636771','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','PTEN','NA','R130*','甲状腺癌','NA','GSK2636771','NCT02465060','Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)','美国、波多黎各','招募中','NA','NA' ) , ( '靶向','RET','NA','M918T','甲状腺癌','髓样癌','LOXO-292','NCT03157128','Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer(LIBRETTO-001)','香港、日本、新加坡、韩国、美国、澳大利亚、法国、瑞士、西班牙','招募中','NA','NA' ) , ( '靶向','RET','NA','M918T','甲状腺癌','髓样癌','BLU-667','NCT03037385','Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors','台湾、新加坡、韩国、美国、法国、德国、意大利、荷兰、英国','招募中','NA','NA' ) , ( '靶向','RET','NA','M918T','甲状腺癌','髓样癌','BOS172738','NCT03780517','Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors','比利时、西班牙、法国','招募中','NA','NA' ) , ( '靶向','RET','NA','C634W','甲状腺癌','髓样癌','LOXO-292','NCT03157128','Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer(LIBRETTO-001)','香港、日本、新加坡、韩国、美国、澳大利亚、法国、瑞士、西班牙','招募中','NA','NA' ) , ( '靶向','RET','NA','C634W','甲状腺癌','髓样癌','BLU-667','NCT03037385','Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors','台湾、新加坡、韩国、美国、法国、德国、意大利、荷兰、英国','招募中','NA','NA' ) , ( '靶向','RET','NA','C634W','甲状腺癌','髓样癌','BOS172738','NCT03780517','Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors','比利时、西班牙、法国','招募中','NA','NA' ) , ( '靶向','RET','NA','C609Y','甲状腺癌','髓样癌','LOXO-292','NCT03157128','Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer(LIBRETTO-001)','香港、日本、新加坡、韩国、美国、澳大利亚、法国、瑞士、西班牙','招募中','NA','NA' ) , ( '靶向','RET','NA','C609Y','甲状腺癌','髓样癌','BLU-667','NCT03037385','Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors','台湾、新加坡、韩国、美国、法国、德国、意大利、荷兰、英国','招募中','NA','NA' ) , ( '靶向','RET','NA','C609Y','甲状腺癌','髓样癌','BOS172738','NCT03780517','Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors','比利时、西班牙、法国','招募中','NA','NA' ) , ( '靶向','RET','NA','KIF5B-RET','肺癌','非小细胞#非鳞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','RET','NA','KIF5B-RET','肺癌','非小细胞#非鳞','BLU-667','NCT03037385','Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors','台湾、新加坡、韩国、美国、法国、德国、意大利、荷兰、英国','招募中','NA','NA' ) , ( '靶向','RET','NA','KIF5B-RET','肺癌','非小细胞#非鳞','阿来替尼','NCT03445000','ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer Treatment of Pretreated RET-rearranged Advanced NSCLC (ALERT-lung)','瑞士、西班牙、法国、德国、爱尔兰、荷兰','招募中','NA','NA' ) , ( '靶向','RET','NA','KIF5B-RET','肺癌','非小细胞#非鳞','LOXO-292','NCT03157128','Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer(LIBRETTO-001)','香港、日本、新加坡、韩国、美国、澳大利亚、法国、瑞士、西班牙','招募中','NA','NA' ) , ( '靶向','RET','NA','KIF5B-RET','肺癌','非小细胞#非鳞','MGCD516（Sitravatinib）','NCT02219711','Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer','美国、韩国','招募中','NA','NA' ) , ( '靶向','RET','NA','CCDC6-RET','肺癌','非小细胞#非鳞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','RET','NA','CCDC6-RET','肺癌','非小细胞#非鳞','BLU-667','NCT03037385','Phase 1 Study of the Highly-selective RET Inhibitor BLU-667 in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors','台湾、新加坡、韩国、美国、法国、德国、意大利、荷兰、英国','招募中','NA','NA' ) , ( '靶向','RET','NA','CCDC6-RET','肺癌','非小细胞#非鳞','阿来替尼','NCT03445000','ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer Treatment of Pretreated RET-rearranged Advanced NSCLC (ALERT-lung)','瑞士、西班牙、法国、德国、爱尔兰、荷兰','招募中','NA','NA' ) , ( '靶向','RET','NA','CCDC6-RET','肺癌','非小细胞#非鳞','LOXO-292','NCT03157128','Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer(LIBRETTO-001)','香港、日本、新加坡、韩国、美国、澳大利亚、法国、瑞士、西班牙','招募中','NA','NA' ) , ( '靶向','RET','NA','CCDC6-RET','肺癌','非小细胞#非鳞','MGCD516（Sitravatinib）','NCT02219711','Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer','美国、韩国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','非小细胞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','非小细胞','X-396（Ensartinib）','NCT03608007','X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement','杭州百达制药有限公司','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','非小细胞','Entrectinib','NCT03178552','A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer(NSCLC) (B-FAST)','韩国、日本、泰国、俄罗斯、澳大利亚、美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','非小细胞','RF-A089','CTR20181787','评估RF-A089口服给药的安全性和耐受性，确定口服给药的最大耐受剂量（MTD）和II期临床研究推荐剂量（RP2D），为后续临床试验给药方案和给药剂量提供依据','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','非小细胞','奥卡替尼','CTR20181193','奥卡替尼治疗晚期复治ALK/ROS1阳性非小细胞肺癌I期临床研究','上海市东方医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','非小细胞','X-396（Ensartinib）','CTR20180400','X-396胶囊治疗ROS1阳性非小细胞肺癌的临床研究','上海市胸科医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','肺癌','NA','WX-0593','CTR20170871','WX-0593片在肿患者中安全耐受性、药代和有效性研究','中国医学科学院肿瘤医院、北京肿瘤医院、首都医科大学附属北京胸科医院、 中国医科大学附属第一医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','结直肠癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','重排','癌种未区分','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','X-396（Ensartinib）','NCT03608007','X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement','杭州百达制药有限公司','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','Entrectinib','NCT03178552','A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer(NSCLC) (B-FAST)','韩国、日本、泰国、俄罗斯、澳大利亚、美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','RF-A089','CTR20181787','评估RF-A089口服给药的安全性和耐受性，确定口服给药的最大耐受剂量（MTD）和II期临床研究推荐剂量（RP2D），为后续临床试验给药方案和给药剂量提供依据','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','奥卡替尼','CTR20181193','奥卡替尼治疗晚期复治ALK/ROS1阳性非小细胞肺癌I期临床研究','上海市东方医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','X-396（Ensartinib）','CTR20180400','X-396胶囊治疗ROS1阳性非小细胞肺癌的临床研究','上海市胸科医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2032R','肺癌','非小细胞#非鳞','WX-0593','CTR20170871','WX-0593片在肿患者中安全耐受性、药代和有效性研究','中国医学科学院肿瘤医院、北京肿瘤医院、首都医科大学附属北京胸科医院、 中国医科大学附属第一医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','X-396（Ensartinib）','NCT03608007','X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement','杭州百达制药有限公司','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','Entrectinib','NCT03178552','A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer(NSCLC) (B-FAST)','韩国、日本、泰国、俄罗斯、澳大利亚、美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','RF-A089','CTR20181787','评估RF-A089口服给药的安全性和耐受性，确定口服给药的最大耐受剂量（MTD）和II期临床研究推荐剂量（RP2D），为后续临床试验给药方案和给药剂量提供依据','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','奥卡替尼','CTR20181193','奥卡替尼治疗晚期复治ALK/ROS1阳性非小细胞肺癌I期临床研究','上海市东方医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','X-396（Ensartinib）','CTR20180400','X-396胶囊治疗ROS1阳性非小细胞肺癌的临床研究','上海市胸科医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','G2032R','肺癌','非小细胞#非鳞','WX-0593','CTR20170871','WX-0593片在肿患者中安全耐受性、药代和有效性研究','中国医学科学院肿瘤医院、北京肿瘤医院、首都医科大学附属北京胸科医院、 中国医科大学附属第一医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','非小细胞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','非小细胞','X-396（Ensartinib）','NCT03608007','X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement','杭州百达制药有限公司','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','非小细胞','Entrectinib','NCT03178552','A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer(NSCLC) (B-FAST)','韩国、日本、泰国、俄罗斯、澳大利亚、美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','非小细胞','RF-A089','CTR20181787','评估RF-A089口服给药的安全性和耐受性，确定口服给药的最大耐受剂量（MTD）和II期临床研究推荐剂量（RP2D），为后续临床试验给药方案和给药剂量提供依据','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','非小细胞','奥卡替尼','CTR20181193','奥卡替尼治疗晚期复治ALK/ROS1阳性非小细胞肺癌I期临床研究','上海市东方医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','非小细胞','X-396（Ensartinib）','CTR20180400','X-396胶囊治疗ROS1阳性非小细胞肺癌的临床研究','上海市胸科医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2026M','肺癌','NA','WX-0593','CTR20170871','WX-0593片在肿患者中安全耐受性、药代和有效性研究','中国医学科学院肿瘤医院、北京肿瘤医院、首都医科大学附属北京胸科医院、 中国医科大学附属第一医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','非小细胞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','非小细胞','X-396（Ensartinib）','NCT03608007','X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement','杭州百达制药有限公司','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','非小细胞','Entrectinib','NCT03178552','A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer(NSCLC) (B-FAST)','韩国、日本、泰国、俄罗斯、澳大利亚、美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','非小细胞','RF-A089','CTR20181787','评估RF-A089口服给药的安全性和耐受性，确定口服给药的最大耐受剂量（MTD）和II期临床研究推荐剂量（RP2D），为后续临床试验给药方案和给药剂量提供依据','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','非小细胞','奥卡替尼','CTR20181193','奥卡替尼治疗晚期复治ALK/ROS1阳性非小细胞肺癌I期临床研究','上海市东方医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','非小细胞','X-396（Ensartinib）','CTR20180400','X-396胶囊治疗ROS1阳性非小细胞肺癌的临床研究','上海市胸科医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 L2155S','肺癌','NA','WX-0593','CTR20170871','WX-0593片在肿患者中安全耐受性、药代和有效性研究','中国医学科学院肿瘤医院、北京肿瘤医院、首都医科大学附属北京胸科医院、 中国医科大学附属第一医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','非小细胞','Cabozantinib','NCT01639508','Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity','美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','非小细胞','X-396（Ensartinib）','NCT03608007','X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement','杭州百达制药有限公司','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','NA','Entrectinib','NCT02568267','Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)','香港、台湾、日本、韩国、新加坡、美国、澳大利亚、比利时、法国、德国、意大利、荷兰、波兰、西班牙','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','非小细胞','Entrectinib','NCT03178552','A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer(NSCLC) (B-FAST)','韩国、日本、泰国、俄罗斯、澳大利亚、美国','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','非小细胞','RF-A089','CTR20181787','评估RF-A089口服给药的安全性和耐受性，确定口服给药的最大耐受剂量（MTD）和II期临床研究推荐剂量（RP2D），为后续临床试验给药方案和给药剂量提供依据','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','非小细胞','奥卡替尼','CTR20181193','奥卡替尼治疗晚期复治ALK/ROS1阳性非小细胞肺癌I期临床研究','上海市东方医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','非小细胞','X-396（Ensartinib）','CTR20180400','X-396胶囊治疗ROS1阳性非小细胞肺癌的临床研究','上海市胸科医院','招募中','NA','NA' ) , ( '靶向','ROS1','NA','CD74-ROS1 G2101A','肺癌','NA','WX-0593','CTR20170871','WX-0593片在肿患者中安全耐受性、药代和有效性研究','中国医学科学院肿瘤医院、北京肿瘤医院、首都医科大学附属北京胸科医院、 中国医科大学附属第一医院','招募中','NA','NA' ) , ( '靶向','SMO','NA','D473H','基底细胞癌','NA','Vismodegib','NCT02436408','VISmodegib for ORbital and Periocular Basal Cell Carcinoma','美国','招募中','NA','NA' ) , ( '靶向','SMO','NA','L412F','基底细胞癌','NA','Vismodegib','NCT02436408','VISmodegib for ORbital and Periocular Basal Cell Carcinoma','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R175H','乳腺癌','HR阳性','Cobimetinib、Idasanutlin','NCT03566485','Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R175H','肺癌','NA','奥希替尼','NCT03567642','A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R175H','神经母细胞瘤','NA','SGT-53','NCT02340156','Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma','美国、台湾','招募中','NA','NA' ) , ( '靶向','TP53','NA','R248Q','乳腺癌','HR阳性','Cobimetinib、Idasanutlin','NCT03566485','Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R248W','肺癌','NA','奥希替尼','NCT03567642','A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R248W','乳腺癌','HR阳性','Cobimetinib、Idasanutlin','NCT03566485','Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R249','乳腺癌','HR阳性','Cobimetinib、Idasanutlin','NCT03566485','Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R273H','乳腺癌','NA','Cobimetinib、Idasanutlin','NCT03566485','Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R273H','肺癌','NA','奥希替尼','NCT03567642','A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','P72R','肺癌','NA','奥希替尼','NCT03567642','A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','R273H','肺癌','NA','奥希替尼','NCT03567642','A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers','美国','招募中','NA','NA' ) , ( '靶向','TP53','NA','P72R','肺癌','NA','奥希替尼','NCT03567642','A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers','美国','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','小细胞','SHR-1316注射液','CTR20182176','SHR-1316/安慰剂联合卡铂和依托泊苷治疗广泛期小细胞肺癌试验','中国医学科学院肿瘤医院等全国多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#非鳞','帕博利珠单抗','CTR20181883','化疗联合帕博利珠单抗治疗TKI耐药EGFRm+转移性非鳞状NSCLC','上海胸科医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#鳞状','注射用SHR-1210（Camrelizumab）','CTR20181611','卡瑞利珠单抗一线治疗肺鳞癌的III期临床研究','同济大学附属上海市肺科医院等全国多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#非鳞','信迪利单抗','CTR20180975','信迪利治疗非鳞状细胞非小细胞肺癌的有效性与安全性','中山大学肿瘤防治中心等全国多家机构','招募中','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','纳武利尤单抗','CTR20180929','比较Nivo联合Ipi或者Nivo联合化疗治疗早期非小细胞肺癌','天津市肿瘤医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','纳武利尤单抗','CTR20180914','比较Nivo, Ipi, 化疗治疗非小细胞肺癌','吉林省肿瘤医院等全球多家机构','招募中','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#鳞状','BGB-A317注射液（Tislelizumab）','CTR20180292','BGB-A317(抗PD-1抗体)联合化疗一线治疗晚期鳞状非小细胞肺癌','北京肿瘤医院等全国多家机构','招募中','健康随我行App','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','小细胞','Tremelimumab','CTR20180090','免疫治疗与以铂类的化疗联合治疗广泛期小细胞肺癌患者','上海市肺科医院等全国','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','小细胞','注射用SHR-1210（Camrelizumab）','CTR20180077','SHR1210联合艾坦治疗小细胞肺癌','中国医学科学院肿瘤医院等全国多家医院','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#非鳞','BGB-A317注射液（Tislelizumab）','CTR20180032','BGB-A317(抗PD-1抗体)联合化疗一线治疗非鳞非小细胞肺癌','上海市胸科医院等全国多家机构','招募中','健康随我行App','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Atezolizumab','CTR20171629','初治晚期或复发性或转移性非小细胞肺癌患者的ATEZOLIZUMAB研究','上海市胸科医院等全球多家机构','招募中','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','重组人源化抗PD-1单克隆抗体注射液（JS001）','CTR20171117','JS001工艺变更前后在晚期NSCLC患者中的PK相似性研究','中国医学科学院肿瘤医院','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','BGB-A317注射液（Tislelizumab）','CTR20171112','非小细胞肺癌患者使用A317对比多西他赛的安全性有效性','上海市肺科医院等全国多家机构','招募中','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','纳武利尤单抗','CTR20171020','亚洲非小细胞肺癌患者接受二线nivolumab单药治疗安全性研究','广东省人民医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Avelumab','CTR20171000','比较avelumab和化疗作为指定非小细胞肺癌治疗的优效性','广东省人民医院等全球多家机构','招募中','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','纳武利尤单抗','CTR20170541','Nivolumab联合治疗EGFR突变阳性的晚期非小细胞肺癌的开放随机试验','广东省人民医院等全国多家机构','招募中','NA','EGFR_T790M#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#鳞状','IBI308','CTR20170380','IBI308或多西他赛二线治疗晚期或转移性鳞状非小细胞肺癌','中国医学科学院肿瘤医院等全国多家机构','招募中','健康随我行App','EGFR突变#ALK突变' ) , ( '免疫','NA','NA','NA','肺癌','NA','BGB-A317注射液（Tislelizumab）','CTR20170361','PD-1联合化疗一线治疗肺癌','中国医学科学院肿瘤医院等全国多家机构','招募中','NA','EGFR突变#ALK突变' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','纳武利尤单抗','CTR20170340','Nivo+Ipi/铂类对比化疗一线治疗非小肺癌患者3期试验','广东省人民医院等全国多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','注射用SHR-1210（Camrelizumab）','CTR20170299','SHR-1210治疗非小细胞肺癌患者的II期临床试验','广东省人民医院','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Durvalumab','CTR20170158','MEDI4736 用于非小细胞肺癌辅助治疗的研究','广东省人民医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#非鳞','Atezolizumab','CTR20170064','评价Atezolizumab联合化疗和培美曲塞治疗非小细胞肺癌的研究','上海市胸科医院等全球多家机构','招募中','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Tremelimumab','CTR20170046','免疫联合治疗与标准治疗用于晚期非小细胞肺癌的研究','吉林省肿瘤医院等全球多家机构','招募中','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#鳞状','帕博利珠单抗','CTR20170044','化疗联合或不联合pembrolizumab在转移性鳞状非小细胞肺癌一线治疗','吉林省肿瘤医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Durvalumab','CTR20170012','Durvalumab用于一线非小细胞肺癌的研究','上海市胸科医院等全球多家机构','招募中','健康随我行App','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','小细胞','Atezolizumab','CTR20160988','卡铂加依托泊苷伴或不伴抗PD-L1抗体治疗广泛期小细胞肺癌','吉林省肿瘤医院等全球多家机构','招募中','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Atezolizumab','CTR20160510','Atezolizumab 对比最佳支持治疗作为非小细胞肺癌患者辅助治疗的试验','中国医学科学院肿瘤医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','帕博利珠单抗','CTR20160205','Pembrolizumab 对比多西他赛作为非小细胞肺癌的二线治疗','上海市肺科医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Ipilimumab','CTR20150661','在选定晚期实体瘤受试者中进行的伊匹木单抗的I期研究','中山大学肿瘤防治中心','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','小细胞','Ipilimumab','CTR20130574','ipilimumab与化疗联合和单纯化疗治疗SCLC患者的疗效比较','广东省人民医院等全球多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','CS1001','CTR20181429','CS1001作为放化疗后巩固治疗在III期NSCLC患者中的III期研究','广东省人民医院等全国多家机构','招募中','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','重组人源化PDL1/CTLA-4双特异性单域抗体Fc融合蛋白注射液','CTR20190195','评估KN046在晚期非小细胞肺癌II 期临床研究','浙江大学附属第一医院','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','重组人源化抗PD-1单克隆抗体注射液（JS001）','CTR20190147','特瑞普利单抗联合化疗治疗非小细胞肺癌有效性、安全性','中国医学科学院肿瘤医院','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#非鳞','注射用卡瑞利珠单抗＋阿帕替尼','CTR20190113','卡瑞利珠单抗＋阿帕替尼治疗KRAS突变非鳞非小细胞肺癌','上海市胸科医院','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#非鳞','信迪利单抗+IBI305','CTR20182559','评估信迪利单抗和 IBI305 联合化疗药用于肺癌患者Ⅲ期研究','上海市胸科医院等全国多家机构','进行中（尚未招募）','NA','ALK重排#ROS1突变#BRAF_V600E' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#鳞状','AK105注射液','CTR20182025','AK105(抗PD-1抗体)或安慰剂联合化疗治疗鳞状非小细胞肺癌','中国人民解放军总医院中国人民解放军总医院','进行中（尚未招募）','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#非鳞','AK105注射液','CTR20182009','AK105(抗PD-1抗体)联合化疗一线治疗非鳞非小细胞肺癌','中国人民解放军总医院','进行中（尚未招募）','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','注射用卡瑞利珠单抗+贝伐珠单抗','CTR20181657','SHR-1210联合BP102治疗非小细胞肺癌的II期研究','浙江大学医学院附属第二医院','进行中（尚未招募）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Atezolizumab','CTR20181628','评价ATEZOLIZUMAB或安慰剂与含铂类药物的疗效和安全性的研究','上海交通大学附属胸科医院','进行中（尚未招募）','NA','EGFR#ALK突变' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','CS1001','CTR20181452','评估CS1001联合化疗一线治疗晚期非小细胞肺癌试验','上海市肺科医院','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞#鳞状','IBI308','CTR20181437','信迪利单抗治疗晚期或转移性鳞状非小细胞肺癌的研究','上海市肺科医院等全国多家机构','进行中（尚未招募）','NA','EGFR突变#ALK重排' ) , ( '免疫','NA','NA','NA','肺癌','非小细胞','Tremelimumab','CTR20180636','免疫治疗与以铂类化疗联合治疗IV期非小细胞肺癌患者','中国医学科学院肿瘤医院等全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','结直肠癌','NA','杰诺单抗(Genolimzumab）+呋喹替尼（Fruquintinib，爱优特）','CTR20182543','杰诺单抗联合呋喹替尼治疗转移性结直肠癌的临床试验','哈尔滨医科大学附属肿瘤医院等全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','结直肠癌','NA','卡瑞利珠单抗（SHR-1210）','CTR20181423','PD-1抗体联合贝伐单抗和XELOX治疗转移性结直肠癌的II期研究','中山大学附属肿瘤医院','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','结直肠癌','NA','杰诺单抗(genolimzumab）','CTR20181174','杰诺单抗联合卡培他滨等药物治疗转移性结直肠癌患者','中国人民解放军第三〇七医院等全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','结直肠癌','NA','KN035注射剂','CTR20181127','单药治疗dMMR/MSI-H晚期结直肠癌及其他晚期实体瘤II期临床研究','北京肿瘤医院消化肿瘤内科等全国多家机构','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','结直肠癌','NA','安美木单抗','CTR20181002','安美木单抗注射液治疗晚期结直肠癌的Ib/II期临床试验','浙江大学医学院附属邵逸夫医院等等全国多家机构','进行中（尚未招募）','NA','KRAS突变#NRAS突变#BRAF_V600E' ) , ( '免疫','NA','NA','NA','结直肠癌','NA','抗原致敏的人树突状细胞','CTR20150633','抗原致敏的人树突状细胞（APDC） 治疗转移性结直肠癌III期研究','中国医学科学院肿瘤医院等全国多家机构','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','胃癌','NA','BAT1306注射液','CTR20181775','BAT1306治疗EBV胃癌','中国人民解放军第八一医院、 同济大学附属上海东方医院等全国多家机构','进行中（尚未招募）','NA','HER2扩增' ) , ( '免疫','NA','NA','NA','胃癌','NA','卡瑞利珠单抗（SHR-1210）','CTR20170750','SHR-1210联合阿帕替尼治疗晚期胃癌和肝细胞癌的探索性临床研究','中国人民解放军第三O七医院','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','胃癌','NA','卡瑞利珠单抗（SHR-1210）','CTR20190072','PD-1抗体SHR-1210治疗胃癌或胃食管交界处癌III期临床研究','北京肿瘤医院','进行中（尚未招募）','健康随我行App','HER2扩增' ) , ( '免疫','NA','NA','NA','胃癌','非鳞','替雷利珠单抗','CTR20181841','对比BGB-A317+化疗与安慰剂+化疗作为胃癌一线治疗安全性和有效性','中山大学肿瘤防治中心等全国多家机构','进行中（尚未招募）','NA','HER2扩增' ) , ( '免疫','NA','NA','NA','胃癌','NA','HX008注射液','CTR20181270','HX008注射液联合化疗治疗晚期胃癌的临床研究','中国人民解放军第三0七医院、哈尔滨医科大学附属肿瘤医院、 浙江大学附属第一医院','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','胃癌','NA','BGB-A317注射液（Tislelizumab）','CTR20170515','PD-1联合化疗一线治疗食管癌、胃癌或胃食管结合部癌','中国人民解放军第307医院等全国多家机构','进行中（招募中）','健康随我行App','HER2扩增' ) , ( '免疫','NA','NA','NA','胃癌','NA','纳武利尤单抗','CTR20170371','Nivolumab+Ipililumab 或 Nivolumab +化疗对比化疗治疗GC或GEJ的三期研究','北京肿瘤医院等全国多家机构','进行中（招募中）','NA','HER2扩增' ) , ( '免疫','NA','NA','NA','食管癌','NA','纳武利尤单抗','CTR20180183','nivolumab对比安慰剂辅助治疗食管癌或胃食管连接部癌','上海市胸科医院等全球多家机构','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','食管癌','NA','卡瑞利珠单抗（SHR-1210）','CTR20181718','SHR-1210联合化疗一线治疗晚期食管癌III期临床研究','中山大学附属肿瘤医院等全国多家机构','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','食管癌','NA','信迪利单抗','CTR20181308','信迪利单抗联合TP方案治疗一线食管鳞癌的研究','北京大学肿瘤医院消化肿瘤内科等多全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','食管癌','鳞状','BGB-A317注射液（Tislelizumab）','CTR20181013','对比BGB-A317与化疗作为食管癌患者一线治疗的有效性和安全性','中国人民解放军第三〇七医院等全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','食管癌','NA','帕博利珠单抗','CTR20171642','一项Pembrolizumab联合化疗一线治疗晚期食管癌的III期临床试验','北京肿瘤医院等全国多家机构','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','食管癌','鳞状','BGB-A317注射液（Tislelizumab）','CTR20171026','对比BGB-A317与化疗作为食管癌患者二线治疗的有效性','北京大学肿瘤医院等全国多家机构','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','食管癌','鳞状','卡瑞利珠单抗（SHR-1210）','CTR20170755','SHR-1210联合放疗治疗局部晚期食管鳞癌的单臂探索性研究','天津市肿瘤医院','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','食管癌','NA','BGB-A317注射液（Tislelizumab）','CTR20170515','PD-1联合化疗一线治疗食管癌、胃癌或胃食管结合部癌','中国人民解放军第307医院等全国多家机构','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','食管癌','NA','卡瑞利珠单抗（SHR-1210）','CTR20170307','SHR-1210对照研究者选择化疗治疗晚期食管癌的III期临床研究','中国医学科学院肿瘤医院等全国多家机构','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','食管癌','NA','IBI308','CTR20170258','评价IBI308对晚期食管癌患者的安全性和有效性','中国人民解放军第三0七医院等全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','黑色素瘤','NA','HX008注射液','CTR20181881','HX008注射液在黑色素瘤患者中的II期临床研究','吉林大学第一医院等全国多家机构','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','黑色素瘤','NA','重组人GM-CSF单纯疱疹病毒注射液','CTR20180505','溶瘤病毒治疗标准方案失败的黑色素瘤肝转移临床试验','北京肿瘤医院','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','黑色素瘤','NA','重组人源化抗PD-1单克隆抗体注射液（JS001）','CTR20180025','JS001对比达卡巴嗪一线治疗不可切除的或转移的黑色素瘤III期','北京肿瘤医院','进行中（招募中）','健康随我行App','BRAF突变' ) , ( '免疫','NA','NA','NA','黑色素瘤','NA','重组人GM-CSF单纯疱疹病毒注射液','CTR20171275','OrienX010瘤内注射治疗不可切除黑色素瘤的II期临床研究','北京肿瘤医院等全国多家机构','进行中（招募中）','NA','NA' ) , ( '免疫','NA','NA','NA','黑色素瘤','NA','重组人源化抗PD-1单克隆抗体注射液（JS001）','CTR20170779','PD-1黏膜黑色素瘤II期临床研究','北京肿瘤医院','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','黑色素瘤','NA','重组人源化抗PD-1单克隆抗体注射液（JS001）','CTR20170109','PD-1治疗晚期肾癌及黑色素瘤的Ib期临床研究','北京肿瘤医院','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','黑色素瘤','NA','重组人源化抗PD-1单克隆抗体注射液（JS001）','CTR20160900','PD-1治疗晚期黑色素瘤II期临床研究','北京肿瘤医院等全国多家机构','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','肉瘤','软组织','注射用SHR-1210（Camrelizumab）+甲磺酸阿帕替尼片（艾坦）','CTR20181785','SHR-1210联合甲磺酸阿帕替尼治疗软组织肉瘤的II期临床研究','上海市第六人民医院','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','肉瘤','软组织','杰诺单抗(genolimzumab）','CTR20181169','PD-1抗体GB226治疗腺泡状软组织肉瘤患者II期临床研究','中国医学科学院肿瘤医院等全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','肉瘤','腺泡状','杰诺单抗(genolimzumab）','CTR20181170','PD-1抗体GB227治疗腺泡状软组织肉瘤患者II期临床研究','中国医学科学院肿瘤医院等全国多家机构','进行中（尚未招募）','NA','NA' ) , ( '免疫','NA','NA','NA','肉瘤','骨','重组全人抗PD-L1单克隆抗体注射液','CTR20180885','重组全人抗PD-L1单克隆抗体ZKAB001的Ⅰ+Ⅱ期临床研究','上海市第六人民医院','进行中（尚未招募）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','肾癌','NA','重组人源化抗PD-1单克隆抗体注射液（JS001）','CTR20170109','PD-1治疗晚期肾癌及黑色素瘤的Ib期临床研究','北京肿瘤医院','进行中（招募中）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','卵巢癌','NA','6B11抗独特型微抗体负载DC和细胞因子诱导的自体卵巢癌杀伤细胞（6B11－OCIK）注射液','CTR20171659','6B11-OCIK注射液治疗耐药复发型上皮性卵巢癌I期临床研究','北京大学人民医院','进行中（尚未招募）','健康随我行App','NA' ) , ( '免疫','NA','NA','NA','卵巢癌','NA','Atezolizumab','CTR20170612','ATEZOLIZUMAB或安慰剂与紫杉醇、卡铂及贝伐珠单抗治疗卵巢癌研究','复旦大学附属肿瘤医院(上海市肿瘤医院)等全球多家机构','进行中（招募中）','健康随我行App','NA' ) [ RunTime:3.489829s ]
---------------------------------------------------------------

[2020-03-11T16:45:12+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.687359s] [吞吐率：1.45req/s] [内存消耗：6,553.30kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.142808s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.095709s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.097172s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.096297s ]
---------------------------------------------------------------

[2020-03-11T16:49:41+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial?search=%E6%89%A9%E5%A2%9E
[运行时间：0.700405s] [吞吐率：1.43req/s] [内存消耗：6,552.88kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'search' => '扩增',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.155153s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.103007s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%扩增%' OR `gene` LIKE '%扩增%'  OR `phgvs` LIKE '%扩增%'  OR `chgvs` LIKE '%扩增%'  OR `cancer_type` LIKE '%扩增%'  OR `cancer_subtype` LIKE '%扩增%' ) [ RunTime:0.095510s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%扩增%' OR `gene` LIKE '%扩增%'  OR `phgvs` LIKE '%扩增%'  OR `chgvs` LIKE '%扩增%'  OR `cancer_type` LIKE '%扩增%'  OR `cancer_subtype` LIKE '%扩增%' ) LIMIT 0,8 [ RunTime:0.096525s ]
---------------------------------------------------------------

[2020-03-11T16:49:55+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial?search=
[运行时间：0.702879s] [吞吐率：1.42req/s] [内存消耗：6,553.73kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial?search=%E6%89%A9%E5%A2%9E',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'search' => '',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.147312s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.098409s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.099572s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.101246s ]
---------------------------------------------------------------

[2020-03-11T17:07:44+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.235798s] [吞吐率：4.24req/s] [内存消耗：4,672.59kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:07:44+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.217941s] [吞吐率：4.59req/s] [内存消耗：4,290.20kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:07:47+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.771027s] [吞吐率：1.30req/s] [内存消耗：6,728.92kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.169668s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.124055s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.106631s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.106555s ]
---------------------------------------------------------------

[2020-03-11T17:09:20+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.228525s] [吞吐率：4.38req/s] [内存消耗：4,417.91kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:09:20+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.243710s] [吞吐率：4.10req/s] [内存消耗：4,290.20kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:09:22+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.723609s] [吞吐率：1.38req/s] [内存消耗：6,490.97kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.193468s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.089870s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.092182s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.091837s ]
---------------------------------------------------------------

[2020-03-11T17:28:31+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.233936s] [吞吐率：4.27req/s] [内存消耗：4,417.91kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:28:31+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.222298s] [吞吐率：4.50req/s] [内存消耗：4,290.20kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:28:35+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.725933s] [吞吐率：1.38req/s] [内存消耗：6,766.28kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.156544s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.101961s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.093355s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.092871s ]
---------------------------------------------------------------

[2020-03-11T17:28:40+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval/1/edit
[运行时间：0.599678s] [吞吐率：1.67req/s] [内存消耗：6,546.73kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval/<id>/edit',
  'route' => '@admin/drug_approval/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.141174s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.094305s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.094369s ]
---------------------------------------------------------------

[2020-03-11T17:28:45+08:00] ::1 PUT localhost/tumor/public/index.php/admin/approval/1
[运行时间：0.557737s] [吞吐率：1.79req/s] [内存消耗：6,062.13kb] [文件加载：78]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval/<id>',
  'route' => '@admin/drug_approval/update',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '206',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval/1/edit',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'cancer_type' => '肺癌aaaaaa',
  'cancer_subtype' => '非小细胞#非鳞',
  'drug' => '贝伐珠单抗',
  'fda_nccn' => '是',
  'cfda' => '是',
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.151384s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.100871s ]
[ sql ] [ SQL ] UPDATE `tp_approval`  SET `cancer_type` = '肺癌aaaaaa' , `cancer_subtype` = '非小细胞#非鳞' , `drug` = '贝伐珠单抗' , `fda_nccn` = '是' , `cfda` = '是'  WHERE  `id` = 1 [ RunTime:0.106466s ]
---------------------------------------------------------------

[2020-03-11T17:28:47+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.689750s] [吞吐率：1.45req/s] [内存消耗：6,499.16kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.138769s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.091850s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.093550s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.092801s ]
---------------------------------------------------------------

[2020-03-11T17:28:49+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval/1/edit
[运行时间：0.581466s] [吞吐率：1.72req/s] [内存消耗：6,287.77kb] [文件加载：83]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval/<id>/edit',
  'route' => '@admin/drug_approval/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.137861s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.090895s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.090845s ]
---------------------------------------------------------------

[2020-03-11T17:28:54+08:00] ::1 PUT localhost/tumor/public/index.php/admin/approval/1
[运行时间：0.548688s] [吞吐率：1.82req/s] [内存消耗：6,062.10kb] [文件加载：78]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval/<id>',
  'route' => '@admin/drug_approval/update',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '200',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval/1/edit',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'cancer_type' => '肺癌',
  'cancer_subtype' => '非小细胞#非鳞',
  'drug' => '贝伐珠单抗',
  'fda_nccn' => '是',
  'cfda' => '是',
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.137993s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.094336s ]
[ sql ] [ SQL ] UPDATE `tp_approval`  SET `cancer_type` = '肺癌' , `cancer_subtype` = '非小细胞#非鳞' , `drug` = '贝伐珠单抗' , `fda_nccn` = '是' , `cfda` = '是'  WHERE  `id` = 1 [ RunTime:0.096336s ]
---------------------------------------------------------------

[2020-03-11T17:28:57+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.728814s] [吞吐率：1.37req/s] [内存消耗：6,499.06kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.151479s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.101098s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.101816s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.102510s ]
---------------------------------------------------------------

[2020-03-11T17:35:36+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.232400s] [吞吐率：4.30req/s] [内存消耗：4,430.02kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:35:36+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.228583s] [吞吐率：4.37req/s] [内存消耗：4,302.18kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:36:41+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.680241s] [吞吐率：1.47req/s] [内存消耗：6,799.77kb] [文件加载：87]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.135664s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.091296s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.092069s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.091192s ]
---------------------------------------------------------------

[2020-03-11T17:36:47+08:00] ::1 DELETE localhost/tumor/public/index.php/admin/approval/1
[运行时间：0.524211s] [吞吐率：1.91req/s] [内存消耗：6,149.74kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval/<id>',
  'route' => '@admin/drug_approval/delete',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'accept' => '*/*',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.145923s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.095511s ]
[ sql ] [ SQL ] DELETE FROM `tp_approval` WHERE  `id` = 1 [ RunTime:0.097481s ]
---------------------------------------------------------------

[2020-03-11T17:36:54+08:00] ::1 POST localhost/tumor/public/index.php/admin/approval/delAll
[运行时间：0.511738s] [吞吐率：1.95req/s] [内存消耗：6,129.23kb] [文件加载：79]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval/delAll',
  'route' => '@admin/drug_approval/delAll',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '29',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'application/x-www-form-urlencoded; charset=UTF-8',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'ids' => '2,3,4,5,6,7,8',
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.141138s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.095409s ]
[ sql ] [ SQL ] DELETE FROM `tp_approval` WHERE  `id` IN (2,3,4,5,6,7,8) [ RunTime:0.097035s ]
---------------------------------------------------------------

[2020-03-11T17:36:58+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.678561s] [吞吐率：1.47req/s] [内存消耗：6,531.88kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.140496s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.094956s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.095070s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.095479s ]
---------------------------------------------------------------

[2020-03-11T17:37:39+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.213193s] [吞吐率：4.69req/s] [内存消耗：4,430.02kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:37:40+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.212333s] [吞吐率：4.71req/s] [内存消耗：4,302.18kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:37:43+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.666825s] [吞吐率：1.50req/s] [内存消耗：6,508.23kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.137986s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.093528s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.092674s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.093003s ]
---------------------------------------------------------------

[2020-03-11T17:37:51+08:00] ::1 POST localhost/tumor/public/index.php/admin/approval/upload
[运行时间：1.144683s] [吞吐率：0.87req/s] [内存消耗：13,099.34kb] [文件加载：127]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval/upload',
  'route' => '@admin/drug_approval/upload',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'content-length' => '36049',
  'accept' => 'application/json, text/javascript, */*; q=0.01',
  'origin' => 'http://localhost',
  'x-requested-with' => 'XMLHttpRequest',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'cors',
  'content-type' => 'multipart/form-data; boundary=----WebKitFormBoundaryywnV6HZb9jaIEc66',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ sql ] [ DB ] CONNECT:[ UseTime:0.169106s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.097905s ]
[ sql ] [ SQL ] INSERT INTO `tp_approval` (`cancer_type` , `cancer_subtype` , `drug` , `fda_nccn` , `cfda`) VALUES ( '肺癌','非小细胞#非鳞','贝伐珠单抗','是','是' ) , ( '肺癌','非小细胞','吉非替尼','是','是' ) , ( '肺癌','非小细胞','克唑替尼','是','是' ) , ( '肺癌','非小细胞','厄洛替尼','是','是' ) , ( '肺癌','非小细胞','埃克替尼','否','是' ) , ( '肺癌','非小细胞','阿法替尼','是','是' ) , ( '肺癌','非小细胞','塞瑞替尼','是','是' ) , ( '肺癌','非小细胞#鳞状','Necitumumab','是','否' ) , ( '肺癌','非小细胞','Ramucirumab','是','否' ) , ( '肺癌','非小细胞','奥希替尼','是','是' ) , ( '肺癌','非小细胞','Brigatinib','是','否' ) , ( '肺癌','非小细胞','Dabrafenib','是','否' ) , ( '肺癌','非小细胞','Trametinib','是','否' ) , ( '肺癌','非小细胞','安罗替尼','否','是' ) , ( '肺癌','非小细胞','达克替尼','是','否' ) , ( '肺癌','非小细胞','阿来替尼','是','是' ) , ( '肺癌','非小细胞','Lorlatinib','是','否' ) , ( '乳腺癌','HR阳性#HER2阴性','哌柏西利','是','是' ) , ( '乳腺癌','HR阳性#HER2阴性','Ribociclib','是','否' ) , ( '乳腺癌','HER2阳性','Ado-trastuzumab emtansine','是','否' ) , ( '乳腺癌','HER2阳性','帕妥珠单抗','是','是' ) , ( '乳腺癌','HER2阳性','曲妥珠单抗','是','是' ) , ( '乳腺癌','HER2阳性','拉帕替尼','是','是' ) , ( '乳腺癌','HR阳性#HER2阴性','依维莫司','是','否' ) , ( '乳腺癌','HR阳性#HER2阴性','奥拉帕利','是','否' ) , ( '乳腺癌','HER2阳性','Neratinib','是','否' ) , ( '乳腺癌','HR阳性#HER2阴性','Abemaciclib','是','否' ) , ( '乳腺癌','HER2阳性','吡咯替尼','否','是' ) , ( '乳腺癌','HER2阴性','Talazoparib','是','否' ) , ( '乳腺癌','HER2阳性','Trastuzumab-pkrb','是','否' ) , ( '乳腺癌','HER2阳性','Trastuzumab-dttb','是','否' ) , ( '乳腺癌','HR阳性#HER2阴性','Alpelisib','是','否' ) , ( '结直肠癌','NA','西妥昔单抗','是','是' ) , ( '结直肠癌','NA','Panitumumab','是','否' ) , ( '结直肠癌','NA','瑞戈非尼','是','是' ) , ( '结直肠癌','NA','Ziv-aflibercept','是','否' ) , ( '结直肠癌','NA','Ramucirumab','是','否' ) , ( '结直肠癌','NA','贝伐珠单抗','是','是' ) , ( '结直肠癌','NA','呋喹替尼','否','是' ) , ( '结直肠癌','NA','曲妥珠单抗','是','否' ) , ( '结直肠癌','NA','帕妥珠单抗','是','否' ) , ( '结直肠癌','NA','拉帕替尼','是','是' ) , ( '胃癌','非鳞','曲妥珠单抗','是','是' ) , ( '胃食管结合部癌','非鳞','曲妥珠单抗','是','是' ) , ( '胃癌','非鳞','Ramucirumab','是','否' ) , ( '胃食管结合部癌','非鳞','Ramucirumab','是','否' ) , ( '胃癌','NA','阿帕替尼','否','是' ) , ( '胃食管结合部癌','NA','阿帕替尼','否','是' ) , ( '胃癌','HER2阳性','Trastuzumab-pkrb','是','否' ) , ( '胃食管结合部癌','HER2阳性','Trastuzumab-pkrb','是','否' ) , ( '胃癌','HER2阳性','Trastuzumab-dttb','是','否' ) , ( '胃食管结合部癌','HER2阳性','Trastuzumab-dttb','是','否' ) , ( '甲状腺癌','髓样癌','Vandetanib','是','否' ) , ( '甲状腺癌','髓样癌','Cabozantinib','是','否' ) , ( '甲状腺癌','分化型','仑伐替尼','是','否' ) , ( '甲状腺癌','分化型','索拉非尼','是','是' ) , ( '甲状腺癌','未分化型','Dabrafenib','是','否' ) , ( '甲状腺癌','未分化型','Trametinib','是','否' ) , ( '甲状腺癌','NA','舒尼替尼','是','否' ) , ( '甲状腺癌','NA','培唑帕尼','是','否' ) , ( '甲状腺癌','髓样癌','阿昔替尼','是','否' ) , ( '甲状腺癌','分化型','阿昔替尼','是','否' ) , ( '甲状腺癌','髓样癌','依维莫司','是','否' ) , ( '甲状腺癌','分化型','依维莫司','是','否' ) , ( '肾癌','NA','仑伐替尼','是','否' ) , ( '肾癌','NA','Temsirolimus','是','否' ) , ( '肾癌','NA','培唑帕尼','是','是' ) , ( '肾癌','NA','索拉非尼','是','是' ) , ( '肾癌','NA','舒尼替尼','是','是' ) , ( '肾癌','NA','贝伐珠单抗','是','否' ) , ( '肾癌','NA','阿昔替尼','是','是' ) , ( '肾癌','NA','依维莫司','是','是' ) , ( '肾癌','NA','Cabozantinib','是','否' ) , ( '黑色素瘤','NA','维莫非尼','是','是' ) , ( '黑色素瘤','NA','Dabrafenib','是','否' ) , ( '黑色素瘤','NA','Trametinib','是','否' ) , ( '黑色素瘤','NA','Cobimetinib','是','否' ) , ( '黑色素瘤','NA','Encorafenib','是','否' ) , ( '黑色素瘤','NA','Binimetinib','是','否' ) , ( '黑色素瘤','NA','伊马替尼','是','否' ) , ( '胰腺癌','NA','厄洛替尼','是','否' ) , ( '胰腺癌','NA','舒尼替尼','是','否' ) , ( '多发性骨髓瘤','NA','硼替佐米','是','是' ) , ( '多发性骨髓瘤','NA','Carfilzomib','是','否' ) , ( '多发性骨髓瘤','NA','Panobinostat','是','否' ) , ( '多发性骨髓瘤','NA','Daratumumab','是','否' ) , ( '多发性骨髓瘤','NA','枸橼酸伊沙佐米','是','是' ) , ( '多发性骨髓瘤','NA','Elotuzumab','是','否' ) , ( '多发性骨髓瘤','NA','Denosumab','是','否' ) , ( '骨巨细胞瘤','NA','Denosumab','是','否' ) , ( '宫颈癌','NA','贝伐珠单抗','是','否' ) , ( '卵巢癌','NA','奥拉帕利','是','是' ) , ( '卵巢癌','NA','Niraparib','是','否' ) , ( '卵巢癌','NA','贝伐珠单抗','是','否' ) , ( '卵巢癌','NA','Rucaparib','是','否' ) , ( '原发性腹膜癌','NA','奥拉帕利','是','是' ) , ( '原发性腹膜癌','NA','Niraparib','是','否' ) , ( '原发性腹膜癌','NA','贝伐珠单抗','是','否' ) , ( '原发性腹膜癌','NA','Rucaparib','是','否' ) , ( '头颈部肿瘤','鳞状','西妥昔单抗','是','否' ) , ( '神经内分泌肿瘤','NA','兰瑞肽','是','是' ) , ( '神经内分泌肿瘤','NA','舒尼替尼','是','是' ) , ( '神经内分泌肿瘤','NA','依维莫司','是','否' ) , ( '神经母细胞瘤','NA','Dinutuximab','是','否' ) , ( '胃肠道间质瘤','NA','伊马替尼','是','是' ) , ( '胃肠道间质瘤','NA','舒尼替尼','是','是' ) , ( '胃肠道间质瘤','NA','瑞戈非尼','是','是' ) , ( '胃肠道间质瘤','NA','索拉非尼','是','否' ) , ( '胃肠道间质瘤','NA','Nilotinib','是','否' ) , ( '胃肠道间质瘤','NA','Dasatinib','是','否' ) , ( '胃肠道间质瘤','NA','培唑帕尼','是','否' ) , ( '胃肠道间质瘤','NA','依维莫司','是','否' ) , ( '肝癌','NA','瑞戈非尼','是','是' ) , ( '肝癌','NA','索拉非尼','是','是' ) , ( '肝癌','NA','仑伐替尼','是','是' ) , ( '肝癌','NA','Cabozantinib','是','否' ) , ( '肉瘤','软组织','培唑帕尼','是','否' ) , ( '肉瘤','软组织','Olaratumab','是','否' ) , ( '基底细胞癌','NA','Vismodegib','是','否' ) , ( '基底细胞癌','NA','Sonidegib','是','否' ) , ( '神经母细胞瘤','NA','贝伐珠单抗','是','否' ) , ( '癌种未区分','NA','Larotrectinib','是','否' ) , ( '尿路上皮癌','NA','Erdafitinib','是','否' ) , ( '肺癌','非小细胞','纳武利尤单抗','是','是' ) , ( '肺癌','非小细胞','帕博利珠单抗','是','是' ) , ( '肺癌','非小细胞','Atezolizumab','是','否' ) , ( '肺癌','小细胞','Atezolizumab','是','否' ) , ( '肺癌','非小细胞','度伐利尤单抗','是','否' ) , ( '肺癌','小细胞','纳武利尤单抗','是','是' ) , ( '肝癌','NA','纳武利尤单抗','是','是' ) , ( '肝癌','NA','帕博利珠单抗','是','是' ) , ( '宫颈癌','NA','帕博利珠单抗','是','是' ) , ( '黑色素瘤','NA','Ipilimumab','是','否' ) , ( '黑色素瘤','NA','纳武利尤单抗','是','是' ) , ( '黑色素瘤','NA','帕博利珠单抗','是','是' ) , ( '黑色素瘤','NA','特瑞普利单抗','否','是' ) , ( '结直肠癌','NA','Ipilimumab','是','否' ) , ( '结直肠癌','NA','纳武利尤单抗','是','是' ) , ( '尿路上皮癌','NA','纳武利尤单抗','是','是' ) , ( '尿路上皮癌','NA','帕博利珠单抗','是','是' ) , ( '尿路上皮癌','NA','Atezolizumab','是','否' ) , ( '尿路上皮癌','NA','Avelumab','是','否' ) , ( '尿路上皮癌','NA','度伐利尤单抗','是','否' ) , ( '皮肤癌','鳞状','Cemiplimab','是','否' ) , ( '乳腺癌','三阴性','Atezolizumab','是','否' ) , ( '肾癌','NA','Ipilimumab','是','否' ) , ( '肾癌','NA','纳武利尤单抗','是','是' ) , ( '肾癌','NA','帕博利珠单抗','是','是' ) , ( '癌种未区分','NA','帕博利珠单抗','是','是' ) , ( '头颈部肿瘤','鳞状','纳武利尤单抗','是','是' ) , ( '头颈部肿瘤','鳞状','帕博利珠单抗','是','是' ) , ( '胃癌','非鳞','帕博利珠单抗','是','是' ) , ( '胃食管结合部癌','非鳞','帕博利珠单抗','是','是' ) , ( '纵隔大 B 细胞淋巴瘤','NA','帕博利珠单抗','是','是' ) , ( '经典型霍奇金淋巴癌','NA','纳武利尤单抗','是','是' ) , ( '经典型霍奇金淋巴癌','NA','帕博利珠单抗','是','是' ) , ( '默克尔细胞癌','NA','帕博利珠单抗','是','是' ) , ( '默克尔细胞癌','NA','Avelumab','是','否' ) , ( '肺癌','非小细胞','Ipilimumab','是','否' ) , ( '肺癌','小细胞','Ipilimumab','是','否' ) , ( '结直肠癌','NA','帕博利珠单抗','是','否' ) , ( '肺癌','非小细胞','Ado-trastuzumab emtansine','是','否' ) , ( '结直肠癌','NA','维莫非尼','是','否' ) , ( '甲状腺癌','分化型','Dabrafenib','是','否' ) , ( '甲状腺癌','分化型','维莫非尼','是','否' ) , ( '食管癌','NA','帕博利珠单抗','是','是' ) [ RunTime:0.176370s ]
---------------------------------------------------------------

[2020-03-11T17:37:52+08:00] ::1 GET localhost/tumor/public/index.php/admin/approval
[运行时间：0.671026s] [吞吐率：1.49req/s] [内存消耗：6,531.70kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/approval',
  'route' => '@admin/drug_approval/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/approval',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\drug_approval\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.140343s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_approval` [ RunTime:0.094918s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) [ RunTime:0.094949s ]
[ sql ] [ SQL ] SELECT * FROM `tp_approval` WHERE  (  `cancer_type` LIKE '%%' OR `cancer_subtype` LIKE '%%'  OR `drug` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.094249s ]
---------------------------------------------------------------

[2020-03-11T17:39:32+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial
[运行时间：0.722765s] [吞吐率：1.38req/s] [内存消耗：6,568.31kb] [文件加载：85]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial',
  'route' => '@admin/clinical/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\index.html [ array (
  0 => 'list',
  1 => 'search',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.180236s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.094574s ]
[ sql ] [ SQL ] SELECT COUNT(*) AS tp_count FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) [ RunTime:0.096184s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  (  `variant_type` LIKE '%%' OR `gene` LIKE '%%'  OR `phgvs` LIKE '%%'  OR `chgvs` LIKE '%%'  OR `cancer_type` LIKE '%%'  OR `cancer_subtype` LIKE '%%' ) LIMIT 0,8 [ RunTime:0.096484s ]
---------------------------------------------------------------

[2020-03-11T17:39:39+08:00] ::1 GET localhost/tumor/public/index.php/admin/clinicaltrial/1/edit
[运行时间：0.565153s] [吞吐率：1.77req/s] [内存消耗：6,273.91kb] [文件加载：82]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/clinicaltrial/<id>/edit',
  'route' => '@admin/clinical/edit',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
    'complete_match' => true,
  ),
  'var' => 
  array (
    'id' => '1',
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/clinicaltrial',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
  'id' => '1',
)
[ info ] [ DB ] INIT mysql
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\clinical\edit.html [ array (
  0 => 'data',
) ]
[ sql ] [ DB ] CONNECT:[ UseTime:0.133957s ] mysql:host=39.98.157.230;port=3306;dbname=tp5;charset=utf8
[ sql ] [ SQL ] SHOW COLUMNS FROM `tp_clinicaltrial` [ RunTime:0.089992s ]
[ sql ] [ SQL ] SELECT * FROM `tp_clinicaltrial` WHERE  `id` = 1 LIMIT 1 [ RunTime:0.091592s ]
---------------------------------------------------------------

[2020-03-11T17:46:19+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.227099s] [吞吐率：4.40req/s] [内存消耗：4,431.20kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:46:19+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.229964s] [吞吐率：4.35req/s] [内存消耗：4,570.09kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
  0 => 'user',
) ]
---------------------------------------------------------------

[2020-03-11T17:46:38+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.227300s] [吞吐率：4.40req/s] [内存消耗：4,431.42kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:46:39+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.211068s] [吞吐率：4.74req/s] [内存消耗：4,304.63kb] [文件加载：75]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
  0 => 'user',
) ]
---------------------------------------------------------------

[2020-03-11T17:49:23+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.226348s] [吞吐率：4.42req/s] [内存消耗：4,432.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:49:23+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.224263s] [吞吐率：4.46req/s] [内存消耗：4,572.75kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
  0 => 'data',
) ]
---------------------------------------------------------------

[2020-03-11T17:49:39+08:00] ::1 GET localhost/tumor/public/index.php/admin/index
[运行时间：0.225769s] [吞吐率：4.43req/s] [内存消耗：4,432.73kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/index',
  'route' => '@admin/index/index',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'cache-control' => 'max-age=0',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'navigate',
  'sec-fetch-user' => '?1',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/login',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\index.html [ array (
) ]
---------------------------------------------------------------

[2020-03-11T17:49:39+08:00] ::1 GET localhost/tumor/public/index.php/admin/welcome
[运行时间：0.227516s] [吞吐率：4.40req/s] [内存消耗：4,572.75kb] [文件加载：77]
[ info ] [ LANG ] C:\wamp64\www\tumor\thinkphp\lang\zh-cn.php
[ info ] [ ROUTE ] array (
  'rule' => 'admin/welcome',
  'route' => '@admin/index/welcome',
  'option' => 
  array (
    'merge_rule_regex' => false,
    'middleware' => 
    array (
      0 => 'CheckLogin',
    ),
  ),
  'var' => 
  array (
  ),
)
[ info ] [ HEADER ] array (
  'host' => 'localhost',
  'connection' => 'keep-alive',
  'upgrade-insecure-requests' => '1',
  'user-agent' => 'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.19 Safari/537.36',
  'sec-fetch-mode' => 'nested-navigate',
  'accept' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3',
  'sec-fetch-site' => 'same-origin',
  'referer' => 'http://localhost/tumor/public/index.php/admin/index',
  'accept-encoding' => 'gzip, deflate, br',
  'accept-language' => 'zh-CN,zh;q=0.9',
  'cookie' => 'thinkphp_show_page_trace=0|0; PHPSESSID=on51vmvc88qj1an1cme1f1jok2',
)
[ info ] [ PARAM ] array (
)
[ info ] [ VIEW ] C:\wamp64\www\tumor\application\admin\view\index\welcome.html [ array (
  0 => 'data',
) ]
